Burlington Stores (BURL) 10-Q 24 Nov 20 2020 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information	9 Months Ended
	Oct. 31, 2020shares
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Oct. 31, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Trading Symbol	BURL
Entity Registrant Name	BURLINGTON STORES, INC.
Entity Central Index Key	0001579298
Current Fiscal Year End Date	--01-30
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Common Stock, Shares Outstanding	66,240,152
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity File Number	001-36107
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	80-0895227
Entity Address, Address Line One	2006 Route 130 North
Entity Address, City or Town	Burlington
Entity Address, State or Province	NJ
Entity Address, Postal Zip Code	08016
City Area Code	609
Local Phone Number	387-7800
Entity Interactive Data Current	Yes
Title of 12(b) Security	Common stock
Security Exchange Name	NYSE
Document Quarterly Report	true
Document Transition Report	false

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income (Loss) (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Nov. 02, 2019	Oct. 31, 2020	Nov. 02, 2019
REVENUES:
Net sales	$ 1,664,728	$ 1,774,949	$ 3,472,606	$ 5,059,860
Type of Revenue [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Other revenue	$ 2,507	$ 6,634	$ 8,480	$ 17,939
Total revenue	1,667,235	1,781,583	3,481,086	5,077,799
COSTS AND EXPENSES:
Cost of sales	915,847	1,022,912	2,245,581	2,954,651
Selling, general and administrative expenses	645,278	583,641	1,621,964	1,632,862
Costs related to debt issuances and amendments	(719)		3,633	(375)
Depreciation and amortization	54,984	52,729	163,679	155,631
Impairment charges - long-lived assets	2,575		5,575
Other income - net	(1,290)	(9,264)	(4,236)	(13,017)
Loss on extinguishment of debt			202
Interest expense	27,456	12,149	70,508	38,954
Total costs and expenses	1,644,131	1,662,167	4,106,906	4,768,706
Income (loss) before income tax expense (benefit)	23,104	119,416	(625,820)	309,093
Income tax expense (benefit)	15,088	22,957	(253,327)	50,302
Net income (loss)	$ 8,016	$ 96,459	$ (372,493)	$ 258,791
Net income (loss) per common stock - basic	$ 0.12	$ 1.46	$ (5.66)	$ 3.92
Net income (loss) per common stock - diluted	$ 0.12	$ 1.44	$ (5.66)	$ 3.84
Weighted average number of common stock - basic	66,083	65,959	65,867	65,994
Weighted average number of common stock - diluted	66,720	67,159	65,867	67,387

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Nov. 02, 2019	Oct. 31, 2020	Nov. 02, 2019
Statement Of Income And Comprehensive Income [Abstract]
Net income (loss)	$ 8,016	$ 96,459	$ (372,493)	$ 258,791
Interest rate derivative contracts:
Net unrealized gains (losses) arising during the period	583	(1,003)	(11,008)	(14,497)
Reclassification into earnings during the period	2,119	500	5,276	465
Other comprehensive income (loss), net of tax	2,702	(503)	(5,732)	(14,032)
Total comprehensive income (loss)	$ 10,718	$ 95,956	$ (378,225)	$ 244,759

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Oct. 31, 2020	Feb. 01, 2020	Nov. 02, 2019
Current assets:
Cash and cash equivalents	$ 1,348,691	$ 403,074	$ 140,514
Restricted cash and cash equivalents	6,582	6,582	6,582
Accounts receivable—net	72,728	91,508	117,493
Merchandise inventories	866,986	777,248	1,004,386
Assets held for disposal		2,261
Prepaid and other current assets	339,874	136,698	146,170
Total current assets	2,634,861	1,417,371	1,415,145
Property and equipment—net	1,442,358	1,403,173	1,375,484
Operating lease assets	2,465,387	2,397,111	2,338,179
Tradenames	238,000	238,000	238,000
Favorable leases—net	585	731	780
Goodwill	47,064	47,064	47,064
Deferred tax assets	4,596	4,678	4,066
Other assets	75,945	85,731	88,869
Total assets	6,908,796	5,593,859	5,507,587
Current liabilities:
Accounts payable	920,944	759,107	888,434
Current operating lease liabilities	293,765	302,185	293,756
Other current liabilities	522,122	397,032	422,154
Current maturities of long term debt	3,815	3,577	3,302
Total current liabilities	1,740,646	1,461,901	1,607,646
Long term debt	2,169,495	1,001,723	982,348
Long term operating lease liabilities	2,396,315	2,322,000	2,258,130
Other liabilities	111,019	97,798	96,249
Deferred tax liabilities	204,745	182,288	171,626
Commitments and contingencies (Note 12)
Stockholders’ equity:
Preferred stock, $0.0001 par value: authorized: 50,000,000 shares; no shares issued and outstanding
Common stock, $0.0001 par value: Authorized: 500,000,000 shares; Issued: 80,504,439 shares, 79,882,506 shares and 79,808,306 shares, respectively; Outstanding: 66,240,152 shares, 65,929,972 shares and 66,249,941 shares, respectively	7	7	7
Additional paid-in-capital	1,786,600	1,587,146	1,568,538
Accumulated (deficit) earnings	(167,696)	204,797	(1,528)
Accumulated other comprehensive loss	(24,692)	(18,960)	(17,645)
Treasury stock, at cost	(1,307,643)	(1,244,841)	(1,157,784)
Total stockholders' equity	286,576	528,149	391,588
Total liabilities and stockholders' equity	$ 6,908,796	$ 5,593,859	$ 5,507,587

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Oct. 31, 2020	Feb. 01, 2020	Nov. 02, 2019
Statement Of Financial Position [Abstract]
Preferred Stock, Par Value	$ 0.0001	$ 0.0001	$ 0.0001
Preferred Stock, Authorized	50,000,000	50,000,000	50,000,000
Preferred Stock, Issued	0	0	0
Preferred Stock, Outstanding	0	0	0
Common Stock, Par Value	$ 0.0001	$ 0.0001	$ 0.0001
Common Stock, Authorized	500,000,000	500,000,000	500,000,000
Common Stock, Shares Issued	80,504,439	79,882,506	79,808,306
Common Stock, Shares Outstanding	66,240,152	65,929,972	66,249,941

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands		9 Months Ended
		Oct. 31, 2020	Nov. 02, 2019
OPERATING ACTIVITIES
Net (loss) income		$ (372,493)	$ 258,791
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities
Depreciation and amortization		163,679	155,631
Impairment charges—long-lived assets		5,575
Amortization of deferred financing costs		3,111	945
Accretion of long term debt instruments		16,885	610
Deferred income taxes		(19,503)	(1,484)
Non-cash loss on extinguishment of debt		202
Non-cash stock compensation expense	[1]	43,451	30,542
Non-cash lease expense		1,617	10,905
Cash received from landlord allowances		26,043	36,006
Changes in assets and liabilities:
Accounts receivable		44,551	(27,441)
Merchandise inventories		(89,739)	(50,709)
Prepaid and other current assets		(203,174)	(23,067)
Accounts payable		161,317	36,014
Other current liabilities		85,095	52,412
Other long term assets and long term liabilities		5,479	3,362
Other operating activities		10,967	(5,644)
Net cash (used in) provided by operating activities		(116,937)	476,873
INVESTING ACTIVITIES
Cash paid for property and equipment		(214,437)	(259,699)
Lease acquisition costs			(959)
Proceeds from insurance recoveries related to property and equipment			5,131
Other investing activities		(897)	(521)
Net cash (used in) investing activities		(215,334)	(256,048)
FINANCING ACTIVITIES
Proceeds from long term debt—Convertible Note		805,000
Proceeds from long term debt—Secured Note		300,000
Purchase of treasury shares		(62,802)	(236,023)
Proceeds from stock option exercises		24,086	29,001
Deferred financing costs		(28,815)
Other financing activities		(9,581)	(863)
Net cash provided by (used in) financing activities		1,277,888	(207,885)
Increase in cash, cash equivalents, restricted cash and restricted cash equivalents		945,617	12,940
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period		409,656	134,156
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period		1,355,273	147,096
Supplemental disclosure of cash flow information:
Interest paid		42,265	36,823
Income tax payments - net		34,339	89,559
Non-cash investing activities:
Accrued purchases of property and equipment		46,778	63,350
ABL senior secured revolving facility
FINANCING ACTIVITIES
Proceeds from long term debt		400,000	1,294,400
Principal payments on long term debt		$ (150,000)	$ (1,294,400)
[1]	The amounts presented in the table above exclude taxes. For the three and nine month periods ended October 31, 2020, the tax benefit related to the Company’s non-cash stock compensation was approximately $2.3 million and $8.3 million, respectively. For the three and nine month periods ended November 2, 2019, the tax benefit related to the Company’s non-cash stock compensation was approximately $1.7 million and $6.4 million, respectively.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Oct. 31, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	1. Summary of Significant Accounting Policies Basis of Presentation As of October 31, 2020, Burlington Stores, Inc., a Delaware corporation (collectively with its subsidiaries, the Company), through its indirect subsidiary Burlington Coat Factory Warehouse Corporation (BCFWC), operated 769 retail stores. These unaudited Condensed Consolidated Financial Statements include the accounts of Burlington Stores, Inc. and its subsidiaries. All inter-company accounts and transactions have been eliminated in consolidation. The Condensed Consolidated Financial Statements are unaudited, but in the opinion of management reflect all adjustments (which are of a normal and recurring nature) necessary for the fair presentation of the results of operations for the interim periods presented. Certain information and note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) have been condensed or omitted. These Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended February 1, 2020 (Fiscal 2019 10-K). The balance sheet at February 1, 2020 presented herein has been derived from the audited Consolidated Financial Statements contained in the Fiscal 2019 10-K. Because of the COVID-19 pandemic discussed below, and because the Company’s business is seasonal in nature, the operating results for the three and nine month periods ended October 31, 2020 are not necessarily indicative of results for the fiscal year. Accounting policies followed by the Company are described in Note 1, “Summary of Significant Accounting Policies,” included in Part II, Item 8 of the Fiscal 2019 10-K. Fiscal Year The Company defines its fiscal year as the 52- or 53-week period ending on the Saturday closest to January 31. The current fiscal year ending January 30, 2021 (Fiscal 2020) and the prior fiscal year ended February 1, 2020 (Fiscal 2019) both consist of 52 weeks. COVID-19 On March 11, 2020, the World Health Organization declared the novel coronavirus (known as COVID-19) outbreak to be a global pandemic. As a result, the Company began the temporary closing of some of its stores, and effective March 22, 2020, it made the decision to temporarily close all of its stores, distribution centers (other than processing of received inventory) and corporate offices to combat the rapid spread of COVID-19. These developments have caused significant disruptions to the Company’s business and have had a significant adverse impact on its financial condition, results of operations and cash flows, the continuing extent of which will be primarily based on a variety of factors, including the timing and extent of any recovery in traffic and consumer spending at the Company’s stores, as well as any future required store closures because of COVID-19 resurgences. The Company began re-opening stores on May 11, 2020, with the majority of stores, as well as all distribution centers, re-opened by mid-June 2020, and substantially all stores re-opened by the end of the second quarter. However, the Company is In response to the COVID-19 pandemic and the temporary closing of stores, the Company provided two weeks of financial support to associates impacted by these store closures and by the shutdown of distribution centers. The Company temporarily furloughed most store and distribution center associates, as well as some corporate associates, but continued to provide benefits to its furloughed associates in accordance with its benefit plans. In addition, we paid 100% of their medical benefit premiums during the period they were furloughed. During the second quarter, the Company recalled all furloughed associates at its re-opened stores, as well as its corporate and distribution facilities. In order to maintain maximum financial flexibility during these uncertain times, the Company completed several debt transactions in the first quarter of Fiscal 2020. In March 2020, the Company borrowed $400 million on its existing $600 million senior secured asset-based revolving credit facility (the ABL Line of Credit), $150 million of which was repaid during the second quarter. In April 2020, the Company issued $805 million of 2.25% Convertible Senior Notes due 2025 (the Convertible Notes), and BCFWC issued $300 million of 6.25% Senior Secured Notes due 2025 (the Secured Notes). Refer to Note 4, “Long Term Debt,” for further discussion regarding these debt transactions. Additionally, the Company took the following steps to further enhance its financial flexibility: • Carefully managed operating expenses, working capital and capital expenditures, including ceasing substantially all buying activities while stores were closed. The Company subsequently resumed its buying activities, while continuing its conservative approach toward operating expenses and capital expenditures. • Negotiated rent deferral agreements with landlords. • Suspended the Company’s share repurchase program. • The Company’s CEO voluntarily agreed to not take a salary; the Company’s board of directors voluntarily forfeited their cash compensation; the Company’s executive leadership team voluntarily agreed to decrease their salary by 50%; and smaller salary reductions were temporarily put in place for all employees through a certain level. This compensation was reinstated once substantially all of the Company’s stores re-opened. • The annual incentive bonus payments related to Fiscal 2019 performance were delayed to the second quarter of Fiscal 2020, and merit pay increases for Fiscal 2020 were delayed to the third quarter of Fiscal 2020. Due to the aging of inventory related to the temporary store closures discussed above, as well as the impact of seasonality on the Company’s merchandise, the Company recognized inventory markdown reserves of $271.9 million during the three month period ended May 2, 2020. These reserves covered markdowns taken during the second quarter of Fiscal 2020. These charges were included in “Cost of sales” on the Company’s Condensed Consolidated Statement of Income (Loss). On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (the CARES Act) was signed into law, which provides emergency economic assistance for American workers, families and businesses affected by the COVID-19 pandemic. The economic relief package includes government loan enhancement programs and various tax provisions to help improve liquidity for American businesses. Based on the Company’s evaluation of the CARES Act, the Company believes that it qualifies for certain employer refundable payroll credits, deferral of applicable payroll taxes, net operating loss (NOL) carrybacks and immediate expensing for eligible qualified improvement property. The Company recorded a tax expense of $7.2 million and a tax benefit of $80.1 million in its effective income tax rate for the three and nine month periods ended October 31, 2020, respectively, for the increased benefit from NOL carrybacks to earlier years when the tax rate was higher than the current year. The Company estimates that it will obtain a tax refund of $202.1 million from the carryback of federal NOLs, which is included in the line item “Prepaid and other current assets” on the Company’s Condensed Consolidated Balance Sheet. Refer to Note 8, “Income Taxes” for further discussion. The Company could experience other potential adverse impacts as a result of the COVID-19 pandemic, including, but not limited to, charges from adjustments to the carrying amount of goodwill and other intangible assets or long-lived asset impairment charges. In addition, the negative impacts of the COVID-19 pandemic may result in further changes in the amount of valuation allowance required. Actual results may differ materially from the Company’s current estimates as the scope of the COVID-19 pandemic evolves, depending largely, though not exclusively, on the duration and extent of the disruption to its business. Recently Adopted Accounting Standards Reference Rate Reform On March 12, 2020, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2020-04, “Facilitation of the Effects of Reference Rate Reform on Financial Reporting,” which aims to address accounting consequences that could result from the global markets’ anticipated transition away from the use of the London Interbank Offered Rate (LIBOR) and other interbank offered rates to alternative reference rates. The amendments in this update provide optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments in this update apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The optional amendments are effective for all entities as of March 12, 2020, through December 31, 2022. The Company intends to elect to apply certain of the optional expedients when evaluating the impact of reference rate reform on its debt and derivative instruments that reference LIBOR. Intangible Assets On January 26, 2017, the FASB issued ASU 2017-04, “Intangibles—Goodwill and Other: Simplifying the Test for Goodwill Impairment,” which aims to simplify the subsequent measurement of goodwill by eliminating Step 2 from the goodwill impairment test. Under the new guidance, goodwill impairment will be measured as the amount by which the carrying value exceeds the fair value. The loss recognized should not exceed the total amount of goodwill allocated to the reporting unit. The new guidance became effective for the Company as of the beginning of Fiscal 2020. Adoption of this guidance did not have a significant impact on the Company’s consolidated financial statements and notes thereto. In August 2018, the FASB issued ASU 2018-15, “Intangibles—Goodwill and Other—Internal-Use Software: Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract.” This ASU requires that implementation costs incurred in a hosting arrangement that is a service contract be assessed in accordance with the existing guidance in Subtopic 350-40, “Internal-Use Software.” Accordingly, costs incurred during the preliminary project stage must be expensed as incurred, while costs incurred during the application development stage must be capitalized. Capitalized implementation costs associated with a hosting arrangement that is a service contract must be expensed over the term of the hosting arrangement. Additionally, the new guidance requires that the expense of these capitalized costs be presented in the same line item in the statements of income as the fees associated with the hosting element of the arrangement. The new guidance became effective for the Company as of the beginning of Fiscal 2020. Adoption of this guidance did not have a significant impact on the Company’s consolidated financial statements and notes thereto. Pending Accounting Standards Convertible Debt On August 5, 2020, the FASB issued ASU 2020-06, “Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity,” which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments. The new guidance removes from GAAP the separation models for convertible debt with a cash conversion feature. As a result, after adopting the guidance, entities will no longer separately present imbedded conversion features in equity, and will instead account for the convertible debt wholly as debt. Among other things, the new guidance also requires use of the if-converted method when calculating the dilutive impact of convertible debt on earnings per share. The new guidance will be effective for fiscal years beginning after December 15, 2021 and interim periods within those years, and may be early adopted for fiscal years beginning after December 15, 2020 and interim periods within those fiscal years. Entities can elect either the full or modified retrospective method of adoption. While the Company is still in the process of determining the impact of adopting this guidance, it does anticipate that the new guidance will have a material impact on its consolidated financial statements and notes thereto. The Company anticipates a significant reclassification from equity to debt, as well as a reduction in interest expense, due to eliminating the amortization of the debt discount. Additionally, this guidance may cause a change to our diluted share count in certain periods. There were no other new accounting standards that had a material impact on the Company’s Condensed Consolidated Financial Statements and notes thereto during the three and nine month periods ended October 31, 2020, and there were no other new accounting standards or pronouncements that were issued but not yet effective as of October 31, 2020 that the Company expects to have a material impact on its financial position or results of operations upon becoming effective.

Stockholders_ Equity

Stockholders’ Equity	9 Months Ended
	Oct. 31, 2020
Stockholders Equity Note [Abstract]
Stockholders’ Equity	2. Stockholders’ Equity Activity for the three and nine month periods ended October 31, 2020 and November 2, 2019 in the Company’s stockholders’ equity are summarized below: (in thousands, except share data) Common Stock Additional Paid-in Accumulated Accumulated Other Comprehensive Treasury Stock Shares Amount Capital Earnings (Deficit) Loss Shares Amount Total Balance at February 1, 2020 79,882,506 $ 7 $ 1,587,146 $ 204,797 $ (18,960 ) (13,952,534 ) $ (1,244,841 ) $ 528,149 Net loss — — — (333,728 ) — — — (333,728 ) Stock options exercised 180,950 — 1,454 — — — — 1,454 Shares used for tax withholding — — — — — (41,363 ) (7,383 ) (7,383 ) Shares purchased as part of publicly announced programs — — — — — (243,573 ) (50,158 ) (50,158 ) Vesting of restricted shares, net of forfeitures of 4,166 restricted shares 20,715 — — — — — — — Stock based compensation — — 17,352 — — — — 17,352 Equity component of convertible notes issuance, net — — 131,916 — — — — 131,916 Unrealized losses on interest rate derivative contracts, net of related taxes of $3.6 million — — — — (9,609 ) — — (9,609 ) Amount reclassified into earnings, net of related taxes of $0.4 million — — — — 1,108 — — 1,108 Balance at May 2, 2020 80,084,171 $ 7 $ 1,737,868 $ (128,931 ) $ (27,461 ) (14,237,470 ) $ (1,302,382 ) $ 279,101 Net loss — — — (46,781 ) — — — (46,781 ) Stock options exercised 324,500 — 19,530 — — — — 19,530 Shares used for tax withholding — — — — — (13,108 ) (2,350 ) (2,350 ) Vesting of restricted shares, net of forfeitures of 2,499 restricted shares 5,480 — — — — — — — Stock based compensation — — 12,693 — — — — 12,693 Unrealized losses on interest rate derivative contracts, net of related taxes of $0.7 million — — — — (1,982 ) — — (1,982 ) Amount reclassified into earnings, net of related taxes of $0.8 million — — — — 2,049 — — 2,049 Balance at August 1, 2020 80,414,151 7 1,770,091 (175,712 ) (27,394 ) (14,250,578 ) (1,304,732 ) 262,260 Net income — — — 8,016 — — — 8,016 Stock options exercised 67,306 — 3,103 — — — — 3,103 Shares used for tax withholding — — — — — (13,709 ) (2,911 ) (2,911 ) Vesting of restricted shares, net of forfeitures of 508 restricted shares 22,982 — — — — — — — Stock based compensation — — 13,406 — — — — 13,406 Unrealized gains on interest rate derivative contracts, net of related taxes of $0.2 million — — — — 583 — — 583 Amount reclassified into earnings, net of related taxes of $0.8 million — — — — 2,119 — — 2,119 Balance at October 31, 2020 80,504,439 $ 7 $ 1,786,600 $ (167,696 ) $ (24,692 ) (14,264,287 ) $ (1,307,643 ) $ 286,576 (in thousands, except share data) Common Stock Additional Paid-in Accumulated Accumulated Other Comprehensive Treasury Stock Shares Amount Capital Deficit Loss Shares Amount Total Balance at February 2, 2019 79,224,669 $ 7 $ 1,508,996 $ (260,919 ) $ (3,613 ) (12,079,572 ) $ (921,761 ) $ 322,710 Net income — — — 77,765 — — — 77,765 Stock options exercised 110,493 — 1,821 — — — — 1,821 Shares used for tax withholding — — — — — (45,447 ) (7,538 ) (7,538 ) Shares purchased as part of publicly announced programs — — — — — (841,460 ) (122,780 ) (122,780 ) Forfeiture of restricted shares, net of issuance of 1,759 restricted shares (2,585 ) — — — — — — — Stock based compensation — — 9,427 — — — — 9,427 Unrealized losses on interest rate derivative contracts, net of related tax benefit of $1.3 million — — — — (3,272 ) — — (3,272 ) Amount reclassified into earnings, net of related taxes of $0.1 million — — — — (185 ) — — (185 ) Cumulative-effect adjustment — — — 600 — — — 600 Balance at May 4, 2019 79,332,577 $ 7 $ 1,520,244 $ (182,554 ) $ (7,070 ) (12,966,479 ) $ (1,052,079 ) $ 278,548 Net income — — — 84,567 — — — 84,567 Stock options exercised 280,955 — 13,394 — — — — 13,394 Shares used for tax withholding — — — — — (67,539 ) (11,521 ) (11,521 ) Shares purchased as part of publicly announced programs — — — — — (300,742 ) (51,326 ) (51,326 ) Forfeiture of restricted shares (8,164 ) — — — — — — — Stock based compensation — — 11,547 — — — — 11,547 Unrealized losses on interest rate derivative contracts, net of related tax benefit of $3.9 million — — — — (10,222 ) — — (10,222 ) Amount reclassified into earnings, net of related taxes of $0.1 million — — — — 150 — — 150 Balance at August 3, 2019 79,605,368 7 1,545,185 (97,987 ) (17,142 ) (13,334,760 ) (1,114,926 ) 315,137 Net income — — — 96,459 — — — 96,459 Stock options exercised 244,805 — 13,785 — — — — 13,785 Shares used for tax withholding — — — — — (596 ) (112 ) (112 ) Shares purchased as part of publicly announced programs — — — — — (223,009 ) (42,746 ) (42,746 ) Forfeiture of restricted shares (41,867 ) — — — — — — — Stock based compensation — — 9,568 — — — — 9,568 Unrealized losses on interest rate derivative contracts, net of related tax benefit of $0.4 million — — — — (1,003 ) — — (1,003 ) Amount reclassified into earnings, net of related taxes of $0.2 million — — — — 500 — — 500 Balance at November 2, 2019 79,808,306 $ 7 $ 1,568,538 $ (1,528 ) $ (17,645 ) (13,558,365 ) $ (1,157,784 ) $ 391,588

Lease Commitments

Lease Commitments	9 Months Ended
	Oct. 31, 2020
Leases [Abstract]
Lease Commitments	3. Lease Commitments The Company’s leases primarily consist of stores, distribution facilities and office space under operating and finance leases that will expire principally during the next 30 years. The leases typically include renewal options at five year intervals and escalation clauses. Lease renewals are only included in the lease liability to the extent that they are reasonably assured of being exercised. The Company’s leases typically provide for contingent rentals based on a percentage of gross sales. Contingent rentals are not included in the lease liability, and they are recognized as variable lease cost when incurred. As a result of the COVID-19 pandemic and the associated temporary store closures discussed above , the Company worked with landlords to modify paymen t terms for certain leas e s . The FASB has pr ovided relief under ASC 842, “Leases,” related to the COVID-19 pandemic. Under thi s relief, c ompanies can make a policy election on how to treat lease concessions resulting directly from COVID-19, provided that the modified contracts result in total cash flows that are substantially the same or less than the cash flows in the original contract. The Company has made the policy election to account for lease concessions that result from the COVID-19 pandemic as if they were m ade as enforceable rights under the original contract. Additionally, the Company has elected to account for these concessions outside of the lease modification framework described under ASC 842. As a result, deferred payments related to these leases of $ 45.6 million are included in the line item “Other current liabilities” on the Company’s Condensed Consolidated Balance Sheet. Due dates for these payments vary by lease, with all payments due before the end of Fiscal 2021. The following is a schedule of the Company’s future lease payments: (in thousands) Fiscal Year Operating Leases Finance Leases 2020 (remainder) $ 84,547 $ 1,517 2021 463,843 6,841 2022 445,106 7,513 2023 421,584 7,589 2024 385,188 7,417 2025 351,492 5,298 Thereafter 1,216,601 33,353 Total future minimum lease payments 3,368,361 69,528 Amount representing interest (678,281 ) (21,177 ) Total lease liabilities 2,690,080 48,351 Less: current portion of lease liabilities (293,765 ) (3,815 ) Total long term lease liabilities $ 2,396,315 $ 44,536 Weighted average discount rate 5.4 % 6.9 % Weighted average remaining lease term (years) 8.3 11.7 The above schedule excludes approximately $324.1 million for 59 stores that the Company has committed to open or relocate but has not yet taken possession of the space. The discount rates used in valuing the Company’s leases are not readily determinable, and are based on the Company’s incremental borrowing rate on a fully collateralized basis. The following is a schedule of net lease costs for the periods indicated: (in thousands) Three Months Ended Nine Months Ended Three Months Ended Nine Months Ended October 31, 2020 October 31, 2020 November 2, 2019 November 2, 2019 Finance lease cost: Amortization of finance lease asset (a) $ 1,212 $ 3,634 $ 973 $ 2,918 Interest on lease liabilities (b) 841 2,570 625 1,921 Operating lease cost (c) 111,797 330,362 104,988 307,416 Variable lease cost (c) 45,110 131,971 38,164 115,425 Total lease cost 158,960 468,537 144,750 427,680 Less all rental income (d) (1,280 ) (3,793 ) (1,265 ) (3,738 ) Total net rent expense (e) $ 157,680 $ 464,744 $ 143,485 $ 423,942 (a) Included in the line item “Depreciation and amortization” in the Company’s Condensed Consolidated Statements of Income (Loss). (b) Included in the line item “Interest expense” in the Company’s Condensed Consolidated Statements of Income (Loss). (c) Includes real estate taxes, common area maintenance, insurance and percentage rent. Included in the line item “Selling, general and administrative expenses” in the Company’s Condensed Consolidated Statements of Income (Loss). (d) Included in the line item “Other revenue” in the Company’s Condensed Consolidated Statements of Income (Loss). (e) Excludes an immaterial amount of short-term lease cost. Supplemental cash flow disclosures related to leases are as follows: (in thousands) Nine Months Ended Nine Months Ended October 31, 2020 November 2, 2019 Cash paid for amounts included in the measurement of lease liabilities: Cash payments arising from operating lease liabilities (a) $ 283,124 $ 296,511 Cash payments for the principal portion of finance lease liabilities (b) $ 2,347 $ 2,133 Cash payments for the interest portion of finance lease liabilities (a) $ 2,570 $ 1,921 Supplemental non-cash information: Operating lease liabilities arising from obtaining right-of-use assets $ 321,688 $ 546,702 (a) Included within operating activities in the Company’s Condensed Consolidated Statements of Cash Flows. (b) Included within financing activities in the Company’s Condensed Consolidated Statements of Cash Flows.

Long Term Debt

Long Term Debt	9 Months Ended
	Oct. 31, 2020
Debt Disclosure [Abstract]
Long Term Debt	4. Long Term Debt Long term debt consists of: (in thousands) October 31, February 1, November 2, 2020 2020 2019 $1,200,000 senior secured term loan facility (Term B-5 Loans), LIBOR (with a floor of 0.00%) plus 1.75% $ 958,222 $ 957,505 $ 957,302 $805,000 convertible senior notes, 2.25%, matures on April 15, 2025 640,618 — — $300,000 senior secured notes, 6.25%, matures on April 15, 2025 300,000 — — $600,000 ABL senior secured revolving facility, LIBOR plus spread based on average outstanding balance, matures on June 29, 2023 250,000 — — Finance lease obligations 48,351 50,130 30,815 Unamortized deferred financing costs (23,881 ) (2,335 ) (2,467 ) Total debt 2,173,310 1,005,300 985,650 Less: current maturities (3,815 ) (3,577 ) (3,302 ) Long term debt, net of current maturities $ 2,169,495 $ 1,001,723 $ 982,348 Term Loan Facility On February 26, 2020, the Company entered into Amendment No. 8 (the Eighth Amendment) to the Term Loan Credit Agreement governing its senior secured credit term loan facility (the Term Loan Facility). The Eighth Amendment, among other things, reduced the interest rate margins applicable to the Term Loan Facility from 1.00% to 0.75%, in the case of prime rate loans, and from 2.00% to 1.75%, in the case of LIBOR loans, with the LIBOR floor remaining at 0.00%. In connection with the execution of the Eighth Amendment, the Company incurred fees of $1.1 million, primarily related to legal and placement fees, which were recorded in the line item “Costs related to debt issuances and amendments” in the Company’s Condensed Consolidated Statement of Income (Loss). Additionally, the Company recognized a non-cash loss on the extinguishment of debt of $0.2 million, representing the write-off of unamortized deferred financing costs and original issue discount, which was recorded in the line item “Loss on extinguishment of debt” in the Company’s Condensed Consolidated Statement of Income (Loss). At October 31, 2020 and November 2, 2019, the Company’s interest rate related to the Term Loan Facility was 1.9 Convertible Notes On April 16, 2020, the Company issued $805 million of Convertible Notes. An aggregate of up to 3,656,149 shares of common stock may be issued upon conversion of the Convertible Notes, which number is subject to adjustment up to an aggregate of 4,844,410 shares following certain corporate events that occur prior to the maturity date or if the Company issues a notice of redemption, and which is also subject to certain anti-dilution adjustments. The Convertible Notes are general unsecured obligations of the Company. The Convertible Notes bear interest at a rate of 2.25% per year, payable semi-annually in cash, in arrears, on April 15 and October 15 of each year, beginning on October 15, 2020. The Convertible Notes will mature on April 15, 2025, unless earlier converted, redeemed or repurchased. Prior to the close of business on the business day immediately preceding January 15, 2025, the Convertible Notes will be convertible at the option of the holders only upon the occurrence of certain events and during certain periods. Thereafter, the Convertible Notes will be convertible at the option of the holders at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. The Convertible Notes have an initial conversion rate of 4.5418 shares per $1,000 principal amount of Convertible Notes (equivalent to an initial conversion price of approximately $220.18 per share of the Company’s common stock), subject to adjustment if certain events occur. The initial conversion price represents a conversion premium of approximately 32.50% over $166.17 per share, the last reported sale price of the Company’s common stock on April 13, 2020 (the pricing date of the offering) on the New York Stock Exchange. Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of its common stock or a combination of cash and shares of its common stock, at its election. The Company may not redeem the Convertible Notes prior to April 15, 2023. On or after April 15, 2023, the Company will be able to redeem for cash all or any portion of the Convertible Notes, at its option, if the last reported sale price of the Company’s common stock is equal to or greater than 130% of the conversion price for a specified period of time, at a redemption price equal to 100% of the principal aggregate amount of the Convertible Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. Holders of the Convertible Notes may require the Company to repurchase their Convertible Notes upon the occurrence of certain events that constitute a fundamental change under the indenture governing the Convertible Notes at a purchase price equal to 100% of the principal amount thereof, plus accrued and unpaid interest to, but excluding, the date of repurchase. In connection with certain corporate events or if the Company issues a notice of redemption, it will, under certain circumstances, increase the conversion rate for holders who elect to convert their Convertible Notes in connection with such corporate event or during the relevant redemption period for such Convertible Notes. The Convertible Notes contain a cash conversion feature, and as a result, the Company has separated it into liability and equity components. The Company valued the liability component based on its borrowing rate for a similar debt instrument that does not contain a conversion feature. The equity component, which is recognized as a debt discount, was valued as the difference between the face value of the Convertible Notes and the fair value of the liability component. In connection with the Convertible Notes issuance, the Company incurred deferred financing costs of $21.0 million, primarily related to fees paid to the bookrunners of the offering, as well as legal, accounting and rating agency fees. These costs were allocated on a pro rata basis, with $16.4 million allocated to the debt component and $4.6 million allocated to the equity component. The debt discount and the debt portion of the deferred costs are being amortized to interest expense over the term of the Convertible Notes at an effective interest rate of 8.2%. The Convertible Notes consist of the following components as of the dates indicated: (in thousands) October 31, February 1, November 2, 2020 2020 2019 Liability component: Principal $ 805,000 $ — $ — Unamortized debt discount (164,383 ) — — Unamortized deferred debt costs (14,888 ) — — Net carrying amount $ 625,729 $ — $ — Equity component, net $ 131,916 $ — $ — Interest expense related to the Convertible Notes consists of the following as of the periods indicated: (in thousands) Three Months Ended Nine Months Ended Three Months Ended Nine Months Ended October 31, 2020 October 31, 2020 November 2, 2019 November 2, 2019 Coupon interest $ 4,508 $ 9,864 $ — $ — Amortization of debt discount 7,542 16,295 — — Amortization of deferred debt costs 683 1,476 — — Convertible Notes interest expense $ 12,733 $ 27,635 $ — $ — Secured Notes On April 16, 2020, BCFWC issued $300 million of Secured Notes. The Secured Notes are senior, secured obligations of BCFWC, and interest is payable semiannually in cash, in arrears, at a rate of 6.25% per annum on April 15 and October 15 of each year, beginning on October 15, 2020. The Secured Notes are guaranteed on a senior secured basis by Burlington Coat Factory Holdings, LLC, Burlington Coat Factory Investments Holdings, Inc. and BCFWC’s subsidiaries that guarantee the loans under the Term Loan Facility. The Secured Notes mature on April 15, 2025, unless earlier redeemed or repurchased. In connection with the Secured Notes issuance, the Company incurred deferred financing costs of $7.8 million, primarily related to fees paid to the bookrunners of the offering, as well as legal fees. These costs are being amortized to interest expense over the term of the Secured Notes. The Company incurred additional costs of $2.5 million, primarily related to legal fees, which are recorded in the line item, “Costs related to debt issuances and amendments” in the Company’s Condensed Consolidated Statement of Income (Loss). ABL Line of Credit On March 17, 2020, the Company borrowed $400 million under the ABL Line of Credit as a precautionary measure in order to increase the Company’s cash position and facilitate financial flexibility in light of the uncertainty resulting from COVID-19. The Company repaid $150 million of this amount during the second quarter of Fiscal 2020. At October 31, 2020, the Company had $292.4 million available under the ABL Line of Credit. The maximum borrowings under the ABL Line of Credit during the three and nine month periods ended October 31, 2020 amounted to $250.0 million and $400.0 million, respectively. Average borrowings during the three and nine month periods ended October 31, 2020 amounted to $250.0 million and $276.2 million, respectively, at an average interest rate of 1.6% and 2.0%, respectively. At November 2, 2019, the Company had $540.8 million available under the ABL Line of Credit. The maximum borrowings under the ABL Line of Credit during the three and nine month periods ended November 2, 2019 amounted to $120.0 million and $255.0 million, respectively. Average borrowings during the three and nine month periods ended November 2, 2019 amounted to $32.6 million and $108.7 million, respectively, at an average interest rate of 3.5% and 3.7%, respectively.

Derivative Instruments and Hedg

Derivative Instruments and Hedging Activities	9 Months Ended
	Oct. 31, 2020
Derivative Instruments And Hedging Activities Disclosure [Abstract]
Derivative Instruments and Hedging Activities	5. Derivative Instruments and Hedging Activities The Company accounts for derivatives and hedging activities in accordance with ASC Topic No. 815, “Derivatives and Hedging” (Topic No. 815). As required by Topic No. 815, the Company records all derivatives on the balance sheet at fair value and adjusts to market on a quarterly basis. In addition, to comply with the provisions of ASC Topic No. 820, “Fair Value Measurements” (Topic No. 820), credit valuation adjustments, which consider the impact of any credit enhancements to the contracts, are incorporated in the fair values to account for potential nonperformance risk. In adjusting the fair value of its derivative contracts for the effect of nonperformance risk, the Company has considered any applicable credit enhancements such as collateral postings, thresholds, mutual puts, and guarantees. In accordance with Topic No. 820, the Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio. There is no impact of netting, because the Company has only one derivative. The Company classifies its derivative valuations in Level 2 of the fair value hierarchy. Cash Flow Hedges of Interest Rate Risk The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish these objectives, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable-rate amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. As of October 31, 2020, the Company had the following outstanding interest rate derivative that was designated as a cash flow hedge of interest rate risk: Interest Rate Derivative Number of Instruments Notional Aggregate Principal Amount Interest Cap/Swap Rate Maturity Date Interest rate swap contract One $ 450.0 million 2.72% December 29, 2023 Tabular Disclosure The table below presents the fair value of the Company’s derivative financial instruments on a gross basis as well as their classification on the Company’s Condensed Consolidated Balance Sheets: (in thousands) Fair Values of Derivative Instruments October 31, 2020 February 1, 2020 November 2, 2019 Derivatives Designated as Hedging Instruments Balance Sheet Location Fair Value Balance Sheet Location Fair Value Balance Sheet Location Fair Value Interest rate swap contract Other liabilities $ 34,076 Other liabilities $ 26,220 Other liabilities $ 24,410 The following table presents the unrealized gains and losses deferred to accumulated other comprehensive loss resulting from the Company’s derivative financial instruments for each of the reporting periods. (in thousands) Three Months Ended Nine Months Ended Interest Rate Derivatives: October 31, 2020 November 2, 2019 October 31, 2020 November 2, 2019 Unrealized gains (losses), before taxes $ 804 $ (1,387 ) $ (15,090 ) $ (20,043 ) Income tax expense (benefit) (221 ) 384 4,082 5,546 Unrealized gains (losses), net of taxes $ 583 $ (1,003 ) $ (11,008 ) $ (14,497 ) The following table presents information about the reclassification of gains and losses from accumulated other comprehensive loss into earnings related to the Company’s derivative instruments for each of the reporting periods. (in thousands) Three Months Ended Nine Months Ended Component of Earnings: October 31, 2020 November 2, 2019 October 31, 2020 November 2, 2019 Interest expense $ 2,919 $ 691 $ 7,271 $ 635 Income tax expense (benefit) (800 ) (191 ) (1,995 ) (170 ) Net reclassification into earnings $ 2,119 $ 500 $ 5,276 $ 465 The Company estimates that approximately $11.5 million will be reclassified from accumulated other comprehensive loss into interest expense during the next twelve months.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	9 Months Ended
	Oct. 31, 2020
Equity [Abstract]
Accumulated Other Comprehensive Loss	6. Accumulated Other Comprehensive Loss Amounts included in accumulated other comprehensive loss are recorded net of the related income tax effects. The following table details the changes in accumulated other comprehensive loss: (in thousands) Derivative Instruments Balance at February 1, 2020 $ (18,960 ) Unrealized losses, net of related tax benefit of $4.1 million (11,008 ) Amount reclassified into earnings, net of related taxes of $2.0 million 5,276 Balance at October 31, 2020 $ (24,692 )

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Oct. 31, 2020
Fair Value Disclosures [Abstract]
Fair Value Measurements	7. Fair Value Measurements The Company accounts for fair value measurements in accordance with Topic No. 820, which defines fair value, establishes a framework for measurement and expands disclosure about fair value measurements. Topic No. 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price), and classifies the inputs used to measure fair value into the following hierarchy: Level 1: Quoted prices for identical assets or liabilities in active markets. Level 2: Quoted market prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable. Level 3: Pricing inputs that are unobservable for the assets and liabilities and include situations where there is little, if any, market activity for the assets and liabilities. The inputs into the determination of fair value require significant management judgment or estimation. The carrying amounts of cash equivalents, accounts receivable and accounts payable approximate fair value due to the short-term nature of these instruments. Refer to Note 5, “Derivative Instruments and Hedging Activities,” for further discussion regarding the fair value of the Company’s interest rate swap contract. Financial Assets The fair values of the Company’s financial assets and the hierarchy of the level of inputs as of October 31, 2020, February 1, 2020 and November 2, 2019 are summarized below: (in thousands) Fair Value Measurements at October 31, February 1, November 2, 2020 2020 2019 Level 1 Cash equivalents (including restricted cash) $ 1,001,416 $ 369,733 $ 7,275 Long-Lived Assets Long-lived assets are measured at fair value on a non-recurring basis for purposes of calculating impairment using the fair value hierarchy of Topic No. 820. The fair value of the Company’s long-lived assets is generally calculated using discounted cash flows. During the three and nine months ended October 31, 2020, the Company recorded impairment charges of $2.6 million and $5.6 million, respectively, primarily related to declines in revenues and operating results for 10 stores and 14 stores, respectively. These costs were recorded in the line item “Impairment charges – long-lived assets” in the Company’s Condensed Consolidated Statements of Income (Loss). All of the fixed assets for these stores were fully impaired and therefore had zero fair value as of October 31, 2020, and would be categorized as Level 3 in the fair value hierarchy described above. One of these stores also had a partially impaired lease asset, with a fair value of $2.9 million as of October 31, 2020, and is categorized as Level 3 in the fair value hierarchy described above. Financial Liabilities The fair values of the Company’s financial liabilities are summarized below: (in thousands) October 31, 2020 February 1, 2020 November 2, 2019 Principal Amount Fair Value Principal Amount Fair Value Principal Amount Fair Value Term B-5 Loans $ 961,415 $ 944,590 $ 961,415 $ 959,899 $ 961,415 $ 957,900 Convertible Notes 805,000 918,183 — — — — Secured Notes 300,000 314,625 — — — — ABL Line of Credit 250,000 250,000 — — — — Total debt (a) $ 2,316,415 $ 2,427,398 $ 961,415 $ 959,899 $ 961,415 $ 957,900 (a) The table above excludes finance lease obligations, debt discount and deferred debt costs. The fair values presented herein are based on pertinent information available to management as of the respective period end dates. The estimated fair values of the Company’s debt are classified as Level 2 in the fair value hierarchy, and are based on current market quotes received from inactive markets.

Income Taxes

Income Taxes	9 Months Ended
	Oct. 31, 2020
Income Tax Disclosure [Abstract]
Income Taxes	8. Income Taxes On March 27, 2020, the CARES Act was enacted into law. The CARES Act includes several significant business tax provisions that, among other things, would eliminate the taxable income limit for certain net operating losses (NOLs) and allow businesses to carry back NOLs arising in 2018, 2019, and 2020 to the five prior tax years, loosen the business interest limitation under section 163(j), and correct certain revisions made to qualified improvement property regulations enacted in the 2017 Tax Cuts and Jobs Act. As a result of the CARES Act, to the extent that there are taxable losses at the end of 2020, the Company estimates that it will be able to obtain a tax refund from the carryback of federal NOLs. Income tax benefit was $253.3 million during the nine month period ended October 31, 2020, compared with income tax expense of $50.3 million during the nine month period ended November 2, 2019. The effective tax rate for the nine month period ended October 31, 2020 was 40.5%, compared with 16.3% during the nine month period ended November 2, 2019. The effective tax rate for the nine month period ended October 31, 2020 differs from the federal statutory rate of 21% and is an increase over the prior year primarily due to the Company’s pretax loss and applying various provisions of the CARES Act, namely the benefit related to the carryback of federal NOLs in Fiscal 2020 to earlier tax years with higher tax rates than the current year, which represents a rate impact of 12.8%. Additionally, there was a 4.1% tax rate impact related to permanent benefits related to stock compensation. Net deferred taxes are as follows: (in thousands) October 31, February 1, November 2, 2020 2020 2019 Deferred tax asset $ 4,596 $ 4,678 $ 4,066 Deferred tax liability 204,745 182,288 171,626 Net deferred tax liability $ 200,149 $ 177,610 $ 167,560 Net deferred tax assets relate to Puerto Rico deferred balances that have a future net benefit for tax purposes. Net deferred tax liabilities primarily relate to intangible assets and depreciation expense where the Company has a future obligation for tax purposes. The increase in deferred tax liability is primarily attributable to the tax treatment of certain debt transactions entered into during the first quarter of Fiscal 2020. As of October 31, 2020, the Company had a deferred tax asset related to net operating losses of $22.2 million, inclusive of $21.9 million related to state net operating losses that expire at various dates between 2021 and 2040, as well as $0.3 million related to Puerto Rico net operating losses that will expire in 2025. As of October 31, 2020, the Company had a deferred tax asset related to tax credit carry-forwards of $12.9 million, inclusive of $2.5 million of federal tax credits, which will expire in 2040, and $9.1 million of state tax credit carry-forwards, which will begin to expire in 2021, and $1.3 million of deferred tax assets recorded for Puerto Rico alternative minimum tax credits that have an indefinite life. As of October 31, 2020, February 1, 2020 and November 2, 2019, valuation allowances amounted to $12.4 million, $9.8 million and $8.7 million, respectively, related to state and Puerto Rico net operating losses and state tax credit carry-forwards. The Company believes that it is more likely than not that this portion of state and Puerto Rico net operating losses and state tax credit carry-forwards will not be realized.

Capital Stock

Capital Stock	9 Months Ended
	Oct. 31, 2020
Capital Stock [Abstract]
Capital Stock	9. Capital Stock Treasury Stock The Company accounts for treasury stock under the cost method. During the nine month period ended October 31, 2020, the Company acquired 68,180 shares of common stock from employees for approximately $12.6 million to satisfy their minimum statutory tax withholdings related to the vesting of restricted stock and restricted stock unit awards, which was recorded in the line item “Treasury stock” on the Company’s Condensed Consolidated Balance Sheets, and the line item “Purchase of treasury shares” on the Company’s Condensed Consolidated Statements of Cash Flows. Share Repurchase Program On August 14, 2019, the Company’s Board of Directors authorized the repurchase of up to $400 million of common stock, which is authorized to be executed through August 2021. This repurchase program is funded using the Company’s available cash and borrowings under the ABL Line of Credit. From the beginning of Fiscal 2020 through the time the program was suspended, the Company repurchased 243,573 shares of its common stock for $50.2 million under its share repurchase program, which was recorded in the line item “Treasury stock” on the Company’s Condensed Consolidated Balance Sheets, and the line item “Purchase of treasury shares” on the Company’s Condensed Consolidated Statements of Cash Flows. As part of the Company’s cash management efforts during the COVID-19 pandemic, the Company suspended its share repurchase program in March 2020. As of October 31, 2020, the Company had $348.4 million remaining under its share repurchase authorization.

Net Income (Loss) Per Share

Net Income (Loss) Per Share	9 Months Ended
	Oct. 31, 2020
Earnings Per Share [Abstract]
Net Income (Loss) Per Share	10. Net Income (Loss) Per Share Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted-average number of common shares outstanding. Diluted net income (loss) per share is calculated by dividing net income (loss) by the weighted-average number of common shares and potentially dilutive securities outstanding during the period using the treasury stock method. The following table presents the computation of basic and diluted net income (loss) per share: (in thousands, except per share data) Three Months Ended Nine Months Ended October 31, November 2, October 31, November 2, 2020 2019 2020 2019 Basic net income (loss) per share Net income (loss) $ 8,016 $ 96,459 $ (372,493 ) $ 258,791 Weighted average number of common shares – basic 66,083 65,959 65,867 65,994 Net income (loss) per common share – basic $ 0.12 $ 1.46 $ (5.66 ) $ 3.92 Diluted net income (loss) per share Net income (loss) $ 8,016 $ 96,459 $ (372,493 ) $ 258,791 Shares for basic and diluted net income (loss) per share: Weighted average number of common shares – basic 66,083 65,959 65,867 65,994 Assumed exercise of stock options and vesting of restricted stock 637 1,200 — 1,393 Assumed conversion of convertible debt — — — — Weighted average number of common shares – diluted 66,720 67,159 65,867 67,387 Net income (loss) per common share – diluted $ 0.12 $ 1.44 $ (5.66 ) $ 3.84 All of the Company’s stock option, restricted stock and restricted stock unit awards have an anti-dilutive effect while in a net loss position. Approximately 585,000 and 2,010,000 shares were excluded from diluted net income (loss) per share for the three and nine month periods ended October 31, 2020, respectively, since their effect was anti-dilutive. Approximately 350,000 and 450,000 shares related to the Company’s stock option, restricted stock and restricted stock unit awards were excluded from diluted net income per share for the three and nine month periods ended November 2, 2019, respectively, since their effect was anti-dilutive. During the three and nine months ended October 31, 2020, shares of common stock issuable upon conversion of the Convertible Notes have been excluded from the computation of diluted earnings per share as the effect would be anti-dilutive, since the conversion price of $220.18 exceeded the average market price of the Company’s common stock during the period.

Stock-Based Compensation

Stock-Based Compensation	9 Months Ended
	Oct. 31, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Stock-Based Compensation	11. Stock-Based Compensation As of October 31, 2020, there were 2,424,032 shares of common stock available for issuance under the Company’s 2013 Omnibus Incentive Plan. Non-cash stock compensation expense is as follows: (in thousands) Three Months Ended Nine Months Ended October 31, November 2, October 31, November 2, Type of Non-Cash Stock Compensation 2020 2019 2020 2019 Restricted stock and restricted stock unit grants (a) $ 6,410 $ 3,910 $ 19,048 $ 14,453 Stock option grants (a) 4,679 4,567 15,707 13,751 Performance stock unit grants (a) 2,317 1,091 8,696 2,338 Total (b) $ 13,406 $ 9,568 $ 43,451 $ 30,542 (a) Included in the line item “Selling, general and administrative expenses” in the Company’s Condensed Consolidated Statements of Income (Loss). (b) The amounts presented in the table above exclude taxes. For the three and nine month periods ended October 31, 2020, the tax benefit related to the Company’s non-cash stock compensation was approximately $2.3 million and $8.3 million, respectively. For the three and nine month periods ended November 2, 2019, the tax benefit related to the Company’s non-cash stock compensation was approximately $1.7 million and $6.4 million, respectively. Stock Options Stock option transactions during the nine month period ended October 31, 2020 are summarized as follows: Number of Shares Weighted Average Exercise Price Per Share Options outstanding, February 1, 2020 1,890,955 $ 94.17 Options granted 242,765 180.78 Options exercised (a) (572,756 ) 42.05 Options forfeited (33,421 ) 112.74 Options outstanding, October 31, 2020 1,527,543 $ 127.07 (a) Options exercised during the nine month period ended October 31, 2020 had a total intrinsic value of $ 88.2 The following table summarizes information about the stock options vested and expected to vest during the contractual term of such options as of October 31, 2020: Options Weighted Average Remaining Contractual Life (Years) Weighted Average Exercise Price Aggregate Intrinsic Value (in millions) Vested and expected to vest 1,527,543 6.2 $ 127.07 $ 101.8 The fair value of each stock option granted during the nine month period ended October 31, 2020 was estimated using the Black Scholes option pricing model using the following assumptions: Nine Months Ended October 31, 2020 Risk-free interest rate 0.45% - 1.48% Expected volatility 35% - 36% Expected life (years) 6.25 Contractual life (years) 10.0 Expected dividend yield 0.0% Weighted average grant date fair value of options issued $ 63.62 The expected dividend yield was based on the Company’s expectation of not paying dividends in the near term. Since the Company completed its initial public offering in October 2013, it does not have sufficient history as a publicly traded company to evaluate its volatility factor. As such, the expected stock price volatility is based upon the historical volatility of the stock price over the expected life of the options of peer companies that are publicly traded. The risk free interest rate was based on the U.S. Treasury rates for U.S. Treasury zero-coupon bonds with maturities similar to those of the expected term of the awards being valued. For grants issued during the nine month period ended October 31, 2020 , the expected life of the options was calculated using the simplified method. The simplified method defines the life as the average of the contractual term of the options and the weighted average vesting period for all option tranches. This methodology was utilized due to the relatively short length of time the Company’s common stock has been publicly traded. Restricted Stock Prior to May 1, 2019, the Company granted shares of restricted stock. Grants made on and after May 1, 2019 are in the form of restricted stock units. Restricted stock transactions during the nine month period ended October 31, 2020 are summarized as follows: Number of Shares Weighted Average Grant Date Fair Value Per Award Non-vested awards outstanding, February 1, 2020 451,774 $ 131.03 Awards granted 185,349 186.40 Awards vested (a) (195,842 ) 112.03 Awards forfeited (12,901 ) 142.26 Non-vested awards outstanding, October 31, 2020 428,380 163.41 (a) Restricted stock awards vested during the nine month period ended October 31, 2020 had a total intrinsic value of $36.3 million. The fair value of each share of restricted stock granted during Fiscal 2020 was based upon the closing price of the Company’s common stock on the grant date Performance Stock Units The Company grants performance-based restricted stock units to its senior executives. Vesting of these performance stock units is based on pre-established EBIT margin expansion and sales compounded annual growth rate (CAGR) goals (each weighted equally) over a three-year three-year Performance stock unit transactions during the nine month period ended October 31, 2020 are summarized as follows: Number of Shares Weighted Average Grant Date Fair Value Per Award Non-vested units outstanding, February 1, 2020 80,951 $ 173.87 Units granted 74,783 179.46 Awards forfeited (1,783 ) 170.08 Non-vested units outstanding, October 31, 2020 153,951 176.63

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Oct. 31, 2020
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingencies	12. Commitments and Contingencies Legal Like many retailers, the Company has been named in potential class or collective actions on behalf of groups alleging violations of federal and state wage and hour and other labor statutes, and alleged violations of state consumer and/or privacy protection and other statutes. The Company is involved in a federal wage and hour lawsuit alleging that certain exempt employees were misclassified under the Fair Labor Standards Act (FLSA). In addition, the Company is involved in a putative class action matter raising similar allegations of misclassification under the wage and hour laws of three states. In June 2020, the Company agreed to settle both matters for approximately $ 19.6 million (plus applicable employer-side payroll taxes). The parties are currently working to obtain final Court approval of the settlement. The Company is also party to representative claims under the California Private Attorneys’ General Act and various other lawsuits and regulatory proceedings including, among others, commercial, product, product safety, employee, customer, intellectual property and other claims. Actions against us are in various procedural stages. Many of these proceedings raise factual and legal issues and are subject to uncertainties. While no assurance can be given as to the ultimate outcome of these matters, the Company believes that the final resolution of these actions will not have a material adverse effect on the Company’s results of operations, financial position, liquidity or capital resources. Letters of Credit The Company had letters of credit arrangements with various banks in the aggregate amount of $57.6 million, $53.1 million and $59.2 million as of October 31, 2020, February 1, 2020 and November 2, 2019, respectively. Among these arrangements, as of October 31, 2020, February 1, 2020 and November 2, 2019, the Company had letters of credit outstanding in the amount of $47.2 million, $46.6 million and $50.8 million, respectively, guaranteeing performance under various insurance contracts and utility agreements. In addition, the Company had outstanding letters of credit arrangements in the amounts of $10.4 million, $6.5 million and $8.4 million at October 31, 2020, February 1, 2020 and November 2, 2019, respectively, related to certain merchandising agreements. Based on the terms of the agreement governing the ABL Line of Credit, the Company had the ability to enter into letters of credit up to $292.4 million, $501.8 million and $540.8 million as of October 31, 2020, February 1, 2020 and November 2, 2019, respectively. Purchase Commitments The Company had $1,090.7 million of purchase commitments related to goods that were not received as of October 31, 2020. Death Benefits In November 2005, the Company entered into agreements with three of the Company’s former executives whereby upon each of their deaths the Company will pay $1.0 million to each respective designated beneficiary.

Related Parties

Related Parties	9 Months Ended
	Oct. 31, 2020
Related Party Transactions [Abstract]
Related Parties	13. Related Parties The brother-in-law of one of the Company’s Executive Vice Presidents is an independent sales representative of one of the Company’s suppliers of merchandise inventory. This relationship predated the commencement of the Executive Vice President’s employment with the Company. The Company has determined that the dollar amount of purchases through such supplier represents an insignificant amount of its inventory purchases.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Oct. 31, 2020
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation As of October 31, 2020, Burlington Stores, Inc., a Delaware corporation (collectively with its subsidiaries, the Company), through its indirect subsidiary Burlington Coat Factory Warehouse Corporation (BCFWC), operated 769 retail stores. These unaudited Condensed Consolidated Financial Statements include the accounts of Burlington Stores, Inc. and its subsidiaries. All inter-company accounts and transactions have been eliminated in consolidation. The Condensed Consolidated Financial Statements are unaudited, but in the opinion of management reflect all adjustments (which are of a normal and recurring nature) necessary for the fair presentation of the results of operations for the interim periods presented. Certain information and note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) have been condensed or omitted. These Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended February 1, 2020 (Fiscal 2019 10-K). The balance sheet at February 1, 2020 presented herein has been derived from the audited Consolidated Financial Statements contained in the Fiscal 2019 10-K. Because of the COVID-19 pandemic discussed below, and because the Company’s business is seasonal in nature, the operating results for the three and nine month periods ended October 31, 2020 are not necessarily indicative of results for the fiscal year. Accounting policies followed by the Company are described in Note 1, “Summary of Significant Accounting Policies,” included in Part II, Item 8 of the Fiscal 2019 10-K.
Fiscal Year	Fiscal Year The Company defines its fiscal year as the 52- or 53-week period ending on the Saturday closest to January 31. The current fiscal year ending January 30, 2021 (Fiscal 2020) and the prior fiscal year ended February 1, 2020 (Fiscal 2019) both consist of 52 weeks.
COVID-19	COVID-19 On March 11, 2020, the World Health Organization declared the novel coronavirus (known as COVID-19) outbreak to be a global pandemic. As a result, the Company began the temporary closing of some of its stores, and effective March 22, 2020, it made the decision to temporarily close all of its stores, distribution centers (other than processing of received inventory) and corporate offices to combat the rapid spread of COVID-19. These developments have caused significant disruptions to the Company’s business and have had a significant adverse impact on its financial condition, results of operations and cash flows, the continuing extent of which will be primarily based on a variety of factors, including the timing and extent of any recovery in traffic and consumer spending at the Company’s stores, as well as any future required store closures because of COVID-19 resurgences. The Company began re-opening stores on May 11, 2020, with the majority of stores, as well as all distribution centers, re-opened by mid-June 2020, and substantially all stores re-opened by the end of the second quarter. However, the Company is In response to the COVID-19 pandemic and the temporary closing of stores, the Company provided two weeks of financial support to associates impacted by these store closures and by the shutdown of distribution centers. The Company temporarily furloughed most store and distribution center associates, as well as some corporate associates, but continued to provide benefits to its furloughed associates in accordance with its benefit plans. In addition, we paid 100% of their medical benefit premiums during the period they were furloughed. During the second quarter, the Company recalled all furloughed associates at its re-opened stores, as well as its corporate and distribution facilities. In order to maintain maximum financial flexibility during these uncertain times, the Company completed several debt transactions in the first quarter of Fiscal 2020. In March 2020, the Company borrowed $400 million on its existing $600 million senior secured asset-based revolving credit facility (the ABL Line of Credit), $150 million of which was repaid during the second quarter. In April 2020, the Company issued $805 million of 2.25% Convertible Senior Notes due 2025 (the Convertible Notes), and BCFWC issued $300 million of 6.25% Senior Secured Notes due 2025 (the Secured Notes). Refer to Note 4, “Long Term Debt,” for further discussion regarding these debt transactions. Additionally, the Company took the following steps to further enhance its financial flexibility: • Carefully managed operating expenses, working capital and capital expenditures, including ceasing substantially all buying activities while stores were closed. The Company subsequently resumed its buying activities, while continuing its conservative approach toward operating expenses and capital expenditures. • Negotiated rent deferral agreements with landlords. • Suspended the Company’s share repurchase program. • The Company’s CEO voluntarily agreed to not take a salary; the Company’s board of directors voluntarily forfeited their cash compensation; the Company’s executive leadership team voluntarily agreed to decrease their salary by 50%; and smaller salary reductions were temporarily put in place for all employees through a certain level. This compensation was reinstated once substantially all of the Company’s stores re-opened. • The annual incentive bonus payments related to Fiscal 2019 performance were delayed to the second quarter of Fiscal 2020, and merit pay increases for Fiscal 2020 were delayed to the third quarter of Fiscal 2020. Due to the aging of inventory related to the temporary store closures discussed above, as well as the impact of seasonality on the Company’s merchandise, the Company recognized inventory markdown reserves of $271.9 million during the three month period ended May 2, 2020. These reserves covered markdowns taken during the second quarter of Fiscal 2020. These charges were included in “Cost of sales” on the Company’s Condensed Consolidated Statement of Income (Loss). On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (the CARES Act) was signed into law, which provides emergency economic assistance for American workers, families and businesses affected by the COVID-19 pandemic. The economic relief package includes government loan enhancement programs and various tax provisions to help improve liquidity for American businesses. Based on the Company’s evaluation of the CARES Act, the Company believes that it qualifies for certain employer refundable payroll credits, deferral of applicable payroll taxes, net operating loss (NOL) carrybacks and immediate expensing for eligible qualified improvement property. The Company recorded a tax expense of $7.2 million and a tax benefit of $80.1 million in its effective income tax rate for the three and nine month periods ended October 31, 2020, respectively, for the increased benefit from NOL carrybacks to earlier years when the tax rate was higher than the current year. The Company estimates that it will obtain a tax refund of $202.1 million from the carryback of federal NOLs, which is included in the line item “Prepaid and other current assets” on the Company’s Condensed Consolidated Balance Sheet. Refer to Note 8, “Income Taxes” for further discussion. The Company could experience other potential adverse impacts as a result of the COVID-19 pandemic, including, but not limited to, charges from adjustments to the carrying amount of goodwill and other intangible assets or long-lived asset impairment charges. In addition, the negative impacts of the COVID-19 pandemic may result in further changes in the amount of valuation allowance required. Actual results may differ materially from the Company’s current estimates as the scope of the COVID-19 pandemic evolves, depending largely, though not exclusively, on the duration and extent of the disruption to its business.
Recently Adopted Accounting Standards	Recently Adopted Accounting Standards Reference Rate Reform On March 12, 2020, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2020-04, “Facilitation of the Effects of Reference Rate Reform on Financial Reporting,” which aims to address accounting consequences that could result from the global markets’ anticipated transition away from the use of the London Interbank Offered Rate (LIBOR) and other interbank offered rates to alternative reference rates. The amendments in this update provide optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments in this update apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The optional amendments are effective for all entities as of March 12, 2020, through December 31, 2022. The Company intends to elect to apply certain of the optional expedients when evaluating the impact of reference rate reform on its debt and derivative instruments that reference LIBOR. Intangible Assets On January 26, 2017, the FASB issued ASU 2017-04, “Intangibles—Goodwill and Other: Simplifying the Test for Goodwill Impairment,” which aims to simplify the subsequent measurement of goodwill by eliminating Step 2 from the goodwill impairment test. Under the new guidance, goodwill impairment will be measured as the amount by which the carrying value exceeds the fair value. The loss recognized should not exceed the total amount of goodwill allocated to the reporting unit. The new guidance became effective for the Company as of the beginning of Fiscal 2020. Adoption of this guidance did not have a significant impact on the Company’s consolidated financial statements and notes thereto. In August 2018, the FASB issued ASU 2018-15, “Intangibles—Goodwill and Other—Internal-Use Software: Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract.” This ASU requires that implementation costs incurred in a hosting arrangement that is a service contract be assessed in accordance with the existing guidance in Subtopic 350-40, “Internal-Use Software.” Accordingly, costs incurred during the preliminary project stage must be expensed as incurred, while costs incurred during the application development stage must be capitalized. Capitalized implementation costs associated with a hosting arrangement that is a service contract must be expensed over the term of the hosting arrangement. Additionally, the new guidance requires that the expense of these capitalized costs be presented in the same line item in the statements of income as the fees associated with the hosting element of the arrangement. The new guidance became effective for the Company as of the beginning of Fiscal 2020. Adoption of this guidance did not have a significant impact on the Company’s consolidated financial statements and notes thereto.
Pending Accounting Standards	Pending Accounting Standards Convertible Debt On August 5, 2020, the FASB issued ASU 2020-06, “Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity,” which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments. The new guidance removes from GAAP the separation models for convertible debt with a cash conversion feature. As a result, after adopting the guidance, entities will no longer separately present imbedded conversion features in equity, and will instead account for the convertible debt wholly as debt. Among other things, the new guidance also requires use of the if-converted method when calculating the dilutive impact of convertible debt on earnings per share. The new guidance will be effective for fiscal years beginning after December 15, 2021 and interim periods within those years, and may be early adopted for fiscal years beginning after December 15, 2020 and interim periods within those fiscal years. Entities can elect either the full or modified retrospective method of adoption. While the Company is still in the process of determining the impact of adopting this guidance, it does anticipate that the new guidance will have a material impact on its consolidated financial statements and notes thereto. The Company anticipates a significant reclassification from equity to debt, as well as a reduction in interest expense, due to eliminating the amortization of the debt discount. Additionally, this guidance may cause a change to our diluted share count in certain periods. There were no other new accounting standards that had a material impact on the Company’s Condensed Consolidated Financial Statements and notes thereto during the three and nine month periods ended October 31, 2020, and there were no other new accounting standards or pronouncements that were issued but not yet effective as of October 31, 2020 that the Company expects to have a material impact on its financial position or results of operations upon becoming effective.

Stockholders_ Equity (Tables)

Stockholders’ Equity (Tables)	9 Months Ended
	Oct. 31, 2020
Stockholders Equity Note [Abstract]
Company's Stockholders Equity	Activity for the three and nine month periods ended October 31, 2020 and November 2, 2019 in the Company’s stockholders’ equity are summarized below: (in thousands, except share data) Common Stock Additional Paid-in Accumulated Accumulated Other Comprehensive Treasury Stock Shares Amount Capital Earnings (Deficit) Loss Shares Amount Total Balance at February 1, 2020 79,882,506 $ 7 $ 1,587,146 $ 204,797 $ (18,960 ) (13,952,534 ) $ (1,244,841 ) $ 528,149 Net loss — — — (333,728 ) — — — (333,728 ) Stock options exercised 180,950 — 1,454 — — — — 1,454 Shares used for tax withholding — — — — — (41,363 ) (7,383 ) (7,383 ) Shares purchased as part of publicly announced programs — — — — — (243,573 ) (50,158 ) (50,158 ) Vesting of restricted shares, net of forfeitures of 4,166 restricted shares 20,715 — — — — — — — Stock based compensation — — 17,352 — — — — 17,352 Equity component of convertible notes issuance, net — — 131,916 — — — — 131,916 Unrealized losses on interest rate derivative contracts, net of related taxes of $3.6 million — — — — (9,609 ) — — (9,609 ) Amount reclassified into earnings, net of related taxes of $0.4 million — — — — 1,108 — — 1,108 Balance at May 2, 2020 80,084,171 $ 7 $ 1,737,868 $ (128,931 ) $ (27,461 ) (14,237,470 ) $ (1,302,382 ) $ 279,101 Net loss — — — (46,781 ) — — — (46,781 ) Stock options exercised 324,500 — 19,530 — — — — 19,530 Shares used for tax withholding — — — — — (13,108 ) (2,350 ) (2,350 ) Vesting of restricted shares, net of forfeitures of 2,499 restricted shares 5,480 — — — — — — — Stock based compensation — — 12,693 — — — — 12,693 Unrealized losses on interest rate derivative contracts, net of related taxes of $0.7 million — — — — (1,982 ) — — (1,982 ) Amount reclassified into earnings, net of related taxes of $0.8 million — — — — 2,049 — — 2,049 Balance at August 1, 2020 80,414,151 7 1,770,091 (175,712 ) (27,394 ) (14,250,578 ) (1,304,732 ) 262,260 Net income — — — 8,016 — — — 8,016 Stock options exercised 67,306 — 3,103 — — — — 3,103 Shares used for tax withholding — — — — — (13,709 ) (2,911 ) (2,911 ) Vesting of restricted shares, net of forfeitures of 508 restricted shares 22,982 — — — — — — — Stock based compensation — — 13,406 — — — — 13,406 Unrealized gains on interest rate derivative contracts, net of related taxes of $0.2 million — — — — 583 — — 583 Amount reclassified into earnings, net of related taxes of $0.8 million — — — — 2,119 — — 2,119 Balance at October 31, 2020 80,504,439 $ 7 $ 1,786,600 $ (167,696 ) $ (24,692 ) (14,264,287 ) $ (1,307,643 ) $ 286,576 (in thousands, except share data) Common Stock Additional Paid-in Accumulated Accumulated Other Comprehensive Treasury Stock Shares Amount Capital Deficit Loss Shares Amount Total Balance at February 2, 2019 79,224,669 $ 7 $ 1,508,996 $ (260,919 ) $ (3,613 ) (12,079,572 ) $ (921,761 ) $ 322,710 Net income — — — 77,765 — — — 77,765 Stock options exercised 110,493 — 1,821 — — — — 1,821 Shares used for tax withholding — — — — — (45,447 ) (7,538 ) (7,538 ) Shares purchased as part of publicly announced programs — — — — — (841,460 ) (122,780 ) (122,780 ) Forfeiture of restricted shares, net of issuance of 1,759 restricted shares (2,585 ) — — — — — — — Stock based compensation — — 9,427 — — — — 9,427 Unrealized losses on interest rate derivative contracts, net of related tax benefit of $1.3 million — — — — (3,272 ) — — (3,272 ) Amount reclassified into earnings, net of related taxes of $0.1 million — — — — (185 ) — — (185 ) Cumulative-effect adjustment — — — 600 — — — 600 Balance at May 4, 2019 79,332,577 $ 7 $ 1,520,244 $ (182,554 ) $ (7,070 ) (12,966,479 ) $ (1,052,079 ) $ 278,548 Net income — — — 84,567 — — — 84,567 Stock options exercised 280,955 — 13,394 — — — — 13,394 Shares used for tax withholding — — — — — (67,539 ) (11,521 ) (11,521 ) Shares purchased as part of publicly announced programs — — — — — (300,742 ) (51,326 ) (51,326 ) Forfeiture of restricted shares (8,164 ) — — — — — — — Stock based compensation — — 11,547 — — — — 11,547 Unrealized losses on interest rate derivative contracts, net of related tax benefit of $3.9 million — — — — (10,222 ) — — (10,222 ) Amount reclassified into earnings, net of related taxes of $0.1 million — — — — 150 — — 150 Balance at August 3, 2019 79,605,368 7 1,545,185 (97,987 ) (17,142 ) (13,334,760 ) (1,114,926 ) 315,137 Net income — — — 96,459 — — — 96,459 Stock options exercised 244,805 — 13,785 — — — — 13,785 Shares used for tax withholding — — — — — (596 ) (112 ) (112 ) Shares purchased as part of publicly announced programs — — — — — (223,009 ) (42,746 ) (42,746 ) Forfeiture of restricted shares (41,867 ) — — — — — — — Stock based compensation — — 9,568 — — — — 9,568 Unrealized losses on interest rate derivative contracts, net of related tax benefit of $0.4 million — — — — (1,003 ) — — (1,003 ) Amount reclassified into earnings, net of related taxes of $0.2 million — — — — 500 — — 500 Balance at November 2, 2019 79,808,306 $ 7 $ 1,568,538 $ (1,528 ) $ (17,645 ) (13,558,365 ) $ (1,157,784 ) $ 391,588

Lease Commitments (Tables)

Lease Commitments (Tables)	9 Months Ended
	Oct. 31, 2020
Leases [Abstract]
Future Lease Payments	The following is a schedule of the Company’s future lease payments: (in thousands) Fiscal Year Operating Leases Finance Leases 2020 (remainder) $ 84,547 $ 1,517 2021 463,843 6,841 2022 445,106 7,513 2023 421,584 7,589 2024 385,188 7,417 2025 351,492 5,298 Thereafter 1,216,601 33,353 Total future minimum lease payments 3,368,361 69,528 Amount representing interest (678,281 ) (21,177 ) Total lease liabilities 2,690,080 48,351 Less: current portion of lease liabilities (293,765 ) (3,815 ) Total long term lease liabilities $ 2,396,315 $ 44,536 Weighted average discount rate 5.4 % 6.9 % Weighted average remaining lease term (years) 8.3 11.7
Schedule of Net Lease Costs	The following is a schedule of net lease costs for the periods indicated: (in thousands) Three Months Ended Nine Months Ended Three Months Ended Nine Months Ended October 31, 2020 October 31, 2020 November 2, 2019 November 2, 2019 Finance lease cost: Amortization of finance lease asset (a) $ 1,212 $ 3,634 $ 973 $ 2,918 Interest on lease liabilities (b) 841 2,570 625 1,921 Operating lease cost (c) 111,797 330,362 104,988 307,416 Variable lease cost (c) 45,110 131,971 38,164 115,425 Total lease cost 158,960 468,537 144,750 427,680 Less all rental income (d) (1,280 ) (3,793 ) (1,265 ) (3,738 ) Total net rent expense (e) $ 157,680 $ 464,744 $ 143,485 $ 423,942 (a) Included in the line item “Depreciation and amortization” in the Company’s Condensed Consolidated Statements of Income (Loss). (b) Included in the line item “Interest expense” in the Company’s Condensed Consolidated Statements of Income (Loss). (c) Includes real estate taxes, common area maintenance, insurance and percentage rent. Included in the line item “Selling, general and administrative expenses” in the Company’s Condensed Consolidated Statements of Income (Loss). (d) Included in the line item “Other revenue” in the Company’s Condensed Consolidated Statements of Income (Loss). (e) Excludes an immaterial amount of short-term lease cost.
Schedule of Supplemental Cash Flow Disclosures Related to Leases	Supplemental cash flow disclosures related to leases are as follows: (in thousands) Nine Months Ended Nine Months Ended October 31, 2020 November 2, 2019 Cash paid for amounts included in the measurement of lease liabilities: Cash payments arising from operating lease liabilities (a) $ 283,124 $ 296,511 Cash payments for the principal portion of finance lease liabilities (b) $ 2,347 $ 2,133 Cash payments for the interest portion of finance lease liabilities (a) $ 2,570 $ 1,921 Supplemental non-cash information: Operating lease liabilities arising from obtaining right-of-use assets $ 321,688 $ 546,702 (a) Included within operating activities in the Company’s Condensed Consolidated Statements of Cash Flows. (b) Included within financing activities in the Company’s Condensed Consolidated Statements of Cash Flows.

Long Term Debt (Tables)

Long Term Debt (Tables)	9 Months Ended
	Oct. 31, 2020
Debt Disclosure [Abstract]
Long Term Debt	Long term debt consists of: (in thousands) October 31, February 1, November 2, 2020 2020 2019 $1,200,000 senior secured term loan facility (Term B-5 Loans), LIBOR (with a floor of 0.00%) plus 1.75% $ 958,222 $ 957,505 $ 957,302 $805,000 convertible senior notes, 2.25%, matures on April 15, 2025 640,618 — — $300,000 senior secured notes, 6.25%, matures on April 15, 2025 300,000 — — $600,000 ABL senior secured revolving facility, LIBOR plus spread based on average outstanding balance, matures on June 29, 2023 250,000 — — Finance lease obligations 48,351 50,130 30,815 Unamortized deferred financing costs (23,881 ) (2,335 ) (2,467 ) Total debt 2,173,310 1,005,300 985,650 Less: current maturities (3,815 ) (3,577 ) (3,302 ) Long term debt, net of current maturities $ 2,169,495 $ 1,001,723 $ 982,348
Schedule of Components of Convertible Notes	The Convertible Notes consist of the following components as of the dates indicated: (in thousands) October 31, February 1, November 2, 2020 2020 2019 Liability component: Principal $ 805,000 $ — $ — Unamortized debt discount (164,383 ) — — Unamortized deferred debt costs (14,888 ) — — Net carrying amount $ 625,729 $ — $ — Equity component, net $ 131,916 $ — $ —
Schedule of Interest Expense Related to Convertible Notes	Interest expense related to the Convertible Notes consists of the following as of the periods indicated: (in thousands) Three Months Ended Nine Months Ended Three Months Ended Nine Months Ended October 31, 2020 October 31, 2020 November 2, 2019 November 2, 2019 Coupon interest $ 4,508 $ 9,864 $ — $ — Amortization of debt discount 7,542 16,295 — — Amortization of deferred debt costs 683 1,476 — — Convertible Notes interest expense $ 12,733 $ 27,635 $ — $ —

Derivative Instruments and He_2

Derivative Instruments and Hedging Activities (Tables)	9 Months Ended
	Oct. 31, 2020
Fair Value of Company's Derivative Financial Instruments on Gross Basis as well as Classification	The table below presents the fair value of the Company’s derivative financial instruments on a gross basis as well as their classification on the Company’s Condensed Consolidated Balance Sheets: (in thousands) Fair Values of Derivative Instruments October 31, 2020 February 1, 2020 November 2, 2019 Derivatives Designated as Hedging Instruments Balance Sheet Location Fair Value Balance Sheet Location Fair Value Balance Sheet Location Fair Value Interest rate swap contract Other liabilities $ 34,076 Other liabilities $ 26,220 Other liabilities $ 24,410
Summary of Unrealized Gains and Losses Deferred to Accumulated Other Comprehensive Loss	The following table presents the unrealized gains and losses deferred to accumulated other comprehensive loss resulting from the Company’s derivative financial instruments for each of the reporting periods. (in thousands) Three Months Ended Nine Months Ended Interest Rate Derivatives: October 31, 2020 November 2, 2019 October 31, 2020 November 2, 2019 Unrealized gains (losses), before taxes $ 804 $ (1,387 ) $ (15,090 ) $ (20,043 ) Income tax expense (benefit) (221 ) 384 4,082 5,546 Unrealized gains (losses), net of taxes $ 583 $ (1,003 ) $ (11,008 ) $ (14,497 )
Reclassification of Gains and Losses from Accumulated Other Comprehensive Loss into Earnings	The following table presents information about the reclassification of gains and losses from accumulated other comprehensive loss into earnings related to the Company’s derivative instruments for each of the reporting periods. (in thousands) Three Months Ended Nine Months Ended Component of Earnings: October 31, 2020 November 2, 2019 October 31, 2020 November 2, 2019 Interest expense $ 2,919 $ 691 $ 7,271 $ 635 Income tax expense (benefit) (800 ) (191 ) (1,995 ) (170 ) Net reclassification into earnings $ 2,119 $ 500 $ 5,276 $ 465
Derivatives Designated as Hedging Instruments
Outstanding Interest Rate Derivative in Qualifying Hedging Relationships	As of October 31, 2020, the Company had the following outstanding interest rate derivative that was designated as a cash flow hedge of interest rate risk: Interest Rate Derivative Number of Instruments Notional Aggregate Principal Amount Interest Cap/Swap Rate Maturity Date Interest rate swap contract One $ 450.0 million 2.72% December 29, 2023

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss (Tables)	9 Months Ended
	Oct. 31, 2020
Equity [Abstract]
Changes in Accumulated Other Comprehensive Loss	The following table details the changes in accumulated other comprehensive loss: (in thousands) Derivative Instruments Balance at February 1, 2020 $ (18,960 ) Unrealized losses, net of related tax benefit of $4.1 million (11,008 ) Amount reclassified into earnings, net of related taxes of $2.0 million 5,276 Balance at October 31, 2020 $ (24,692 )

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Oct. 31, 2020
Fair Value Disclosures [Abstract]
Fair Values of Financial Assets and Hierarchy of Level of Inputs	The fair values of the Company’s financial assets and the hierarchy of the level of inputs as of October 31, 2020, February 1, 2020 and November 2, 2019 are summarized below: (in thousands) Fair Value Measurements at October 31, February 1, November 2, 2020 2020 2019 Level 1 Cash equivalents (including restricted cash) $ 1,001,416 $ 369,733 $ 7,275
Fair Values of Financial Liabilities	The fair values of the Company’s financial liabilities are summarized below: (in thousands) October 31, 2020 February 1, 2020 November 2, 2019 Principal Amount Fair Value Principal Amount Fair Value Principal Amount Fair Value Term B-5 Loans $ 961,415 $ 944,590 $ 961,415 $ 959,899 $ 961,415 $ 957,900 Convertible Notes 805,000 918,183 — — — — Secured Notes 300,000 314,625 — — — — ABL Line of Credit 250,000 250,000 — — — — Total debt (a) $ 2,316,415 $ 2,427,398 $ 961,415 $ 959,899 $ 961,415 $ 957,900 (a) The table above excludes finance lease obligations, debt discount and deferred debt costs.

Income Taxes (Tables)

Income Taxes (Tables)	9 Months Ended
	Oct. 31, 2020
Income Tax Disclosure [Abstract]
Net Deferred Taxes	Net deferred taxes are as follows: (in thousands) October 31, February 1, November 2, 2020 2020 2019 Deferred tax asset $ 4,596 $ 4,678 $ 4,066 Deferred tax liability 204,745 182,288 171,626 Net deferred tax liability $ 200,149 $ 177,610 $ 167,560

Net Income (Loss) Per Share (Ta

Net Income (Loss) Per Share (Tables)	9 Months Ended
	Oct. 31, 2020
Earnings Per Share [Abstract]
Computation of Basic and Diluted Net Income (Loss) per Share	The following table presents the computation of basic and diluted net income (loss) per share: (in thousands, except per share data) Three Months Ended Nine Months Ended October 31, November 2, October 31, November 2, 2020 2019 2020 2019 Basic net income (loss) per share Net income (loss) $ 8,016 $ 96,459 $ (372,493 ) $ 258,791 Weighted average number of common shares – basic 66,083 65,959 65,867 65,994 Net income (loss) per common share – basic $ 0.12 $ 1.46 $ (5.66 ) $ 3.92 Diluted net income (loss) per share Net income (loss) $ 8,016 $ 96,459 $ (372,493 ) $ 258,791 Shares for basic and diluted net income (loss) per share: Weighted average number of common shares – basic 66,083 65,959 65,867 65,994 Assumed exercise of stock options and vesting of restricted stock 637 1,200 — 1,393 Assumed conversion of convertible debt — — — — Weighted average number of common shares – diluted 66,720 67,159 65,867 67,387 Net income (loss) per common share – diluted $ 0.12 $ 1.44 $ (5.66 ) $ 3.84

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	9 Months Ended
	Oct. 31, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Non-Cash Stock Compensation Expense	Non-cash stock compensation expense is as follows: (in thousands) Three Months Ended Nine Months Ended October 31, November 2, October 31, November 2, Type of Non-Cash Stock Compensation 2020 2019 2020 2019 Restricted stock and restricted stock unit grants (a) $ 6,410 $ 3,910 $ 19,048 $ 14,453 Stock option grants (a) 4,679 4,567 15,707 13,751 Performance stock unit grants (a) 2,317 1,091 8,696 2,338 Total (b) $ 13,406 $ 9,568 $ 43,451 $ 30,542 (a) Included in the line item “Selling, general and administrative expenses” in the Company’s Condensed Consolidated Statements of Income (Loss). (b) The amounts presented in the table above exclude taxes. For the three and nine month periods ended October 31, 2020, the tax benefit related to the Company’s non-cash stock compensation was approximately $2.3 million and $8.3 million, respectively. For the three and nine month periods ended November 2, 2019, the tax benefit related to the Company’s non-cash stock compensation was approximately $1.7 million and $6.4 million, respectively.
Stock Option Transactions	Stock option transactions during the nine month period ended October 31, 2020 are summarized as follows: Number of Shares Weighted Average Exercise Price Per Share Options outstanding, February 1, 2020 1,890,955 $ 94.17 Options granted 242,765 180.78 Options exercised (a) (572,756 ) 42.05 Options forfeited (33,421 ) 112.74 Options outstanding, October 31, 2020 1,527,543 $ 127.07 (a) Options exercised during the nine month period ended October 31, 2020 had a total intrinsic value of $ 88.2
Stock Options Vested and Expected to Vest	The following table summarizes information about the stock options vested and expected to vest during the contractual term of such options as of October 31, 2020: Options Weighted Average Remaining Contractual Life (Years) Weighted Average Exercise Price Aggregate Intrinsic Value (in millions) Vested and expected to vest 1,527,543 6.2 $ 127.07 $ 101.8
Weighted Average Assumptions Used to Estimate Fair Value of Each Stock Option Granted	The fair value of each stock option granted during the nine month period ended October 31, 2020 was estimated using the Black Scholes option pricing model using the following assumptions: Nine Months Ended October 31, 2020 Risk-free interest rate 0.45% - 1.48% Expected volatility 35% - 36% Expected life (years) 6.25 Contractual life (years) 10.0 Expected dividend yield 0.0% Weighted average grant date fair value of options issued $ 63.62
Award Grant and Vesting Transactions	Restricted stock transactions during the nine month period ended October 31, 2020 are summarized as follows: Number of Shares Weighted Average Grant Date Fair Value Per Award Non-vested awards outstanding, February 1, 2020 451,774 $ 131.03 Awards granted 185,349 186.40 Awards vested (a) (195,842 ) 112.03 Awards forfeited (12,901 ) 142.26 Non-vested awards outstanding, October 31, 2020 428,380 163.41 (a) Restricted stock awards vested during the nine month period ended October 31, 2020 had a total intrinsic value of $36.3 million.
Performance Stock Unit Transactions	Performance stock unit transactions during the nine month period ended October 31, 2020 are summarized as follows: Number of Shares Weighted Average Grant Date Fair Value Per Award Non-vested units outstanding, February 1, 2020 80,951 $ 173.87 Units granted 74,783 179.46 Awards forfeited (1,783 ) 170.08 Non-vested units outstanding, October 31, 2020 153,951 176.63

Summary of Significant Accoun_3

Summary of Significant Accounting Policies - Additional Information (Detail) $ in Thousands	3 Months Ended				9 Months Ended
	Oct. 31, 2020USD ($)Store	Aug. 01, 2020USD ($)	May 02, 2020USD ($)	Nov. 02, 2019USD ($)	Oct. 31, 2020USD ($)Store	Nov. 02, 2019USD ($)	Apr. 30, 2020USD ($)	Apr. 16, 2020USD ($)	Mar. 31, 2020USD ($)	Mar. 17, 2020USD ($)
Summary Of Significant Accounting Policies [Line Items]
Number of stores operated | Store	769				769
Medical benefit premiums paid during period furloughed	100.00%				100.00%
Decrease salary of executive leadership team					50.00%
Inventory markdown reserve			$ 271,900
Income tax expense (benefit)	$ 15,088			$ 22,957	$ (253,327)	$ 50,302
Coronavirus Aid, Relief, and Economic Security Act
Summary Of Significant Accounting Policies [Line Items]
Income tax expense (benefit)	7,200				(80,100)
Coronavirus Aid, Relief, and Economic Security Act | Prepaid and Other Current Assets
Summary Of Significant Accounting Policies [Line Items]
Tax refund from carryback of federal net operating loss	202,100				202,100
ABL senior secured revolving facility
Summary Of Significant Accounting Policies [Line Items]
Long Term Debt	250,000				250,000				$ 400,000
Repayments of debt		$ 150,000
Long-Term Debt, face amount	600,000				600,000				$ 600,000	$ 400,000
Convertible Senior Notes
Summary Of Significant Accounting Policies [Line Items]
Long Term Debt	640,618				640,618
Long-Term Debt, face amount	$ 805,000				$ 805,000		$ 805,000	$ 805,000
Debt Instrument, Interest Rate, Stated Percentage	2.25%				2.25%		2.25%	2.25%
Senior Secured Notes
Summary Of Significant Accounting Policies [Line Items]
Long Term Debt	$ 300,000				$ 300,000
Long-Term Debt, face amount	$ 300,000				$ 300,000		$ 300,000	$ 300,000
Debt Instrument, Interest Rate, Stated Percentage	6.25%				6.25%		6.25%	6.25%

Company's Stockholders Equity (

Company's Stockholders Equity (Detail) - USD ($) $ in Thousands		3 Months Ended						9 Months Ended
		Oct. 31, 2020	Aug. 01, 2020	May 02, 2020	Nov. 02, 2019	Aug. 03, 2019	May 04, 2019	Oct. 31, 2020	Nov. 02, 2019
Balance at beginning of period		$ 262,260	$ 279,101	$ 528,149	$ 315,137	$ 278,548	$ 322,710	$ 528,149	$ 322,710
Net (loss) income		8,016	(46,781)	(333,728)	96,459	84,567	77,765	$ (372,493)	$ 258,791
Stock options exercised		3,103	19,530	1,454	13,785	13,394	1,821
Stock options exercised (in shares)	[1]							572,756
Shares used for tax withholding		$ (2,911)	(2,350)	(7,383)	(112)	(11,521)	(7,538)
Shares purchased as part of publicly announced programs				(50,158)	$ (42,746)	(51,326)	(122,780)
Vesting of restricted shares, net of forfeitures of restricted shares		637,000			1,200,000				1,393,000
Stock based compensation		$ 13,406	12,693	17,352	$ 9,568	11,547	9,427
Equity component of convertible notes issuance, net				131,916
Unrealized gains (losses) on interest rate derivative contracts, net of related taxes benefit		583	(1,982)	(9,609)	(1,003)	(10,222)	(3,272)	$ (11,008)	$ (14,497)
Amount reclassified into earnings, net of related taxes		2,119	2,049	1,108	500	150	(185)	5,276	465
Balance at end of period		286,576	262,260	279,101	391,588	315,137	278,548	286,576	391,588
Cumulative-effect Adjustment
Balance at beginning of period							600		600
Common Stock
Balance at beginning of period		$ 7	$ 7	$ 7	$ 7	$ 7	$ 7	$ 7	$ 7
Balance at beginning of period (in shares)		80,414,151	80,084,171	79,882,506	79,605,368	79,332,577	79,224,669	79,882,506	79,224,669
Stock options exercised (in shares)		67,306	324,500	180,950	244,805	280,955	110,493
Vesting of restricted shares, net of forfeitures of restricted shares		22,982	5,480	20,715
Forfeiture of restricted shares, net of issuance of restricted shares							(2,585)
Forfeiture of restricted shares (in shares)					(41,867)	(8,164)
Balance at end of period		$ 7	$ 7	$ 7	$ 7	$ 7	$ 7	$ 7	$ 7
Balance at end of period (in shares)		80,504,439	80,414,151	80,084,171	79,808,306	79,605,368	79,332,577	80,504,439	79,808,306
Additional Paid-in Capital
Balance at beginning of period		$ 1,770,091	$ 1,737,868	$ 1,587,146	$ 1,545,185	$ 1,520,244	$ 1,508,996	$ 1,587,146	$ 1,508,996
Stock options exercised		3,103	19,530	1,454	13,785	13,394	1,821
Stock based compensation		13,406	12,693	17,352	9,568	11,547	9,427
Equity component of convertible notes issuance, net				131,916
Balance at end of period		1,786,600	1,770,091	1,737,868	1,568,538	1,545,185	1,520,244	1,786,600	1,568,538
Accumulated Earnings (Deficit)
Balance at beginning of period		(175,712)	(128,931)	204,797	(97,987)	(182,554)	(260,919)	204,797	(260,919)
Net (loss) income		8,016	(46,781)	(333,728)	96,459	84,567	77,765
Balance at end of period		(167,696)	(175,712)	(128,931)	(1,528)	(97,987)	(182,554)	(167,696)	(1,528)
Accumulated Earnings (Deficit) | Cumulative-effect Adjustment
Balance at beginning of period							600		600
Accumulated Other Comprehensive Loss
Balance at beginning of period		(27,394)	(27,461)	(18,960)	(17,142)	(7,070)	(3,613)	(18,960)	(3,613)
Unrealized gains (losses) on interest rate derivative contracts, net of related taxes benefit		583	(1,982)	(9,609)	(1,003)	(10,222)	(3,272)
Amount reclassified into earnings, net of related taxes		2,119	2,049	1,108	500	150	(185)
Balance at end of period		(24,692)	(27,394)	(27,461)	(17,645)	(17,142)	(7,070)	(24,692)	(17,645)
Treasury Stock
Balance at beginning of period		$ (1,304,732)	$ (1,302,382)	$ (1,244,841)	$ (1,114,926)	$ (1,052,079)	$ (921,761)	$ (1,244,841)	$ (921,761)
Balance at beginning of period (in shares)		(14,250,578)	(14,237,470)	(13,952,534)	(13,334,760)	(12,966,479)	(12,079,572)	(13,952,534)	(12,079,572)
Shares used for tax withholding		$ (2,911)	$ (2,350)	$ (7,383)	$ (112)	$ (11,521)	$ (7,538)
Shares used for tax withholding (in shares)		(13,709)	(13,108)	(41,363)	(596)	(67,539)	(45,447)
Shares purchased as part of publicly announced programs				$ (50,158)	$ (42,746)	$ (51,326)	$ (122,780)
Shares purchased as part of publicly announced programs, (in shares)				(243,573)	(223,009)	(300,742)	(841,460)
Balance at end of period		$ (1,307,643)	$ (1,304,732)	$ (1,302,382)	$ (1,157,784)	$ (1,114,926)	$ (1,052,079)	$ (1,307,643)	$ (1,157,784)
Balance at end of period (in shares)		(14,264,287)	(14,250,578)	(14,237,470)	(13,558,365)	(13,334,760)	(12,966,479)	(14,264,287)	(13,558,365)
[1]	Options exercised during the nine month period ended October 31, 2020 had a total intrinsic value of $ 88.2

Company's Stockholders Equity_2

Company's Stockholders Equity (Parenthetical) (Detail) - USD ($) $ in Millions	3 Months Ended
	Oct. 31, 2020	Aug. 01, 2020	May 02, 2020	Nov. 02, 2019	Aug. 03, 2019	May 04, 2019
Statement Of Stockholders Equity [Abstract]
Forfeited restricted shares	508	2,499	4,166			1,759
Unrealized gains (losses) on interest rate derivative contracts, Tax	$ 0.2	$ 0.7	$ 3.6	$ 0.4	$ 3.9	$ 1.3
Amount reclassified into earnings on Interest Rate Cap Contracts, Tax	$ 0.8	$ 0.8	$ 0.4	$ 0.2	$ 0.1	$ 0.1

Lease Commitments - Additional

Lease Commitments - Additional Information (Detail) $ in Millions	9 Months Ended
	Oct. 31, 2020USD ($)Store
Future Minimum Payments Receivable [Line Items]
Operating and finance leases, expiration period	30 years
Leases renewal option	5 years
Accrued lease liability	$ 324.1
Number of store committed to open or relocate but has not yet taken possession | Store	59
Other Current Liabilities | Coronavirus Aid, Relief, and Economic Security Act
Future Minimum Payments Receivable [Line Items]
Deferred lease payments	$ 45.6

Future Lease Payments (Detail)

Future Lease Payments (Detail) - USD ($) $ in Thousands	Oct. 31, 2020	Feb. 01, 2020	Nov. 02, 2019
Operating Leases
2020 (remainder)	$ 84,547
2021	463,843
2022	445,106
2023	421,584
2024	385,188
2025	351,492
Thereafter	1,216,601
Total future minimum lease payments	3,368,361
Amount representing interest	(678,281)
Total lease liabilities	2,690,080
Less: current portion of lease liabilities	(293,765)	$ (302,185)	$ (293,756)
Total long term lease liabilities	$ 2,396,315	$ 2,322,000	$ 2,258,130
Weighted average discount rate	5.40%
Weighted average remaining lease term (years)	8 years 3 months 18 days
Finance Leases
2020 (remainder)	$ 1,517
2021	6,841
2022	7,513
2023	7,589
2024	7,417
2025	5,298
Thereafter	33,353
Total future minimum lease payments	69,528
Amount representing interest	(21,177)
Total lease liabilities	48,351
Less: current portion of lease liabilities	(3,815)
Total long term lease liabilities	$ 44,536
Weighted average discount rate	6.90%
Weighted average remaining lease term (years)	11 years 8 months 12 days

Schedule of Net Lease Costs (De

Schedule of Net Lease Costs (Detail) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Oct. 31, 2020	Nov. 02, 2019	Oct. 31, 2020	Nov. 02, 2019
Finance lease cost:
Amortization of finance lease asset	[1]	$ 1,212	$ 973	$ 3,634	$ 2,918
Interest on lease liabilities	[2]	841	625	2,570	1,921
Operating lease cost	[3]	111,797	104,988	330,362	307,416
Variable lease cost	[3]	45,110	38,164	131,971	115,425
Total lease cost		158,960	144,750	468,537	427,680
Less all rental income	[4]	(1,280)	(1,265)	(3,793)	(3,738)
Total net rent expense	[5]	$ 157,680	$ 143,485	$ 464,744	$ 423,942
[1]	Included in the line item “Depreciation and amortization” in the Company’s Condensed Consolidated Statements of Income (Loss).
[2]	Included in the line item “Interest expense” in the Company’s Condensed Consolidated Statements of Income (Loss).
[3]	Includes real estate taxes, common area maintenance, insurance and percentage rent. Included in the line item “Selling, general and administrative expenses” in the Company’s Condensed Consolidated Statements of Income (Loss).
[4]	Included in the line item “Other revenue” in the Company’s Condensed Consolidated Statements of Income (Loss).
[5]	Excludes an immaterial amount of short-term lease cost.

Schedule of Supplemental Cash F

Schedule of Supplemental Cash Flow Disclosures Related to Leases (Details) - USD ($) $ in Thousands		9 Months Ended
		Oct. 31, 2020	Nov. 02, 2019
Cash paid for amounts included in the measurement of lease liabilities:
Cash payments arising from operating lease liabilities	[1]	$ 283,124	$ 296,511
Cash payments for the principal portion of finance lease liabilities	[2]	2,347	2,133
Cash payments for the interest portion of finance lease liabilities	[1]	2,570	1,921
Operating lease liabilities arising from obtaining right-of-use assets		$ 321,688	$ 546,702
[1]	Included within operating activities in the Company’s Condensed Consolidated Statements of Cash Flows.
[2]	Included within financing activities in the Company’s Condensed Consolidated Statements of Cash Flows.

Long-Term Debt (Detail)

Long-Term Debt (Detail) - USD ($) $ in Thousands	Oct. 31, 2020	Apr. 16, 2020	Mar. 31, 2020	Feb. 01, 2020	Nov. 02, 2019
Debt Instrument [Line Items]
Finance lease obligations	$ 48,351			$ 50,130	$ 30,815
Unamortized deferred financing costs	(23,881)			(2,335)	(2,467)
Total debt	2,173,310			1,005,300	985,650
Less: current maturities	(3,815)			(3,577)	(3,302)
Long term debt, net of current maturities	2,169,495			1,001,723	982,348
Senior Secured Term B-5 Loans
Debt Instrument [Line Items]
Long Term Debt	958,222			$ 957,505	$ 957,302
Convertible Senior Notes
Debt Instrument [Line Items]
Long Term Debt	640,618
Unamortized deferred financing costs		$ (21,000)
Senior Secured Notes
Debt Instrument [Line Items]
Long Term Debt	300,000
Unamortized deferred financing costs		$ (7,800)
ABL senior secured revolving facility
Debt Instrument [Line Items]
Long Term Debt	$ 250,000		$ 400,000

Long-Term Debt (Parenthetical)

Long-Term Debt (Parenthetical) (Detail) - USD ($) $ in Thousands	Apr. 16, 2020	Oct. 31, 2020	Nov. 02, 2019	Feb. 01, 2020	Apr. 30, 2020	Mar. 31, 2020	Mar. 17, 2020
Senior Secured Term B-5 Loans
Debt Instrument [Line Items]
Long-Term Debt, maturity date		Nov. 17, 2024	Nov. 17, 2024	Nov. 17, 2024
Long-Term Debt, face amount		$ 1,200,000	$ 1,200,000	$ 1,200,000
Convertible Senior Notes
Debt Instrument [Line Items]
Long-Term Debt, maturity date	Apr. 15, 2025	Apr. 15, 2025
Long-Term Debt, face amount	$ 805,000	$ 805,000			$ 805,000
Long-Term Debt, interest rate	2.25%	2.25%			2.25%
ABL senior secured revolving facility
Debt Instrument [Line Items]
Long-Term Debt, maturity date		Jun. 29, 2023
Long-Term Debt, face amount		$ 600,000				$ 600,000	$ 400,000
Senior Secured Notes
Debt Instrument [Line Items]
Long-Term Debt, maturity date	Apr. 15, 2025	Apr. 15, 2025
Long-Term Debt, face amount	$ 300,000	$ 300,000			$ 300,000
Long-Term Debt, interest rate	6.25%	6.25%			6.25%
London Interbank Offered Rate Floor | Senior Secured Term B-5 Loans
Debt Instrument [Line Items]
Long-Term Debt, interest rate		0.00%	0.00%	0.00%
London Interbank Offered Rate (LIBOR) | Senior Secured Term B-5 Loans
Debt Instrument [Line Items]
Long-Term Debt, interest rate		1.75%	1.75%	1.75%

Long-Term Debt - Additional Inf

Long-Term Debt - Additional Information (Detail)	Apr. 16, 2020USD ($)shares$ / shares	Feb. 26, 2020USD ($)	Feb. 25, 2020	Oct. 31, 2020USD ($)$ / shares	Aug. 01, 2020USD ($)	Nov. 02, 2019USD ($)	Oct. 31, 2020USD ($)$ / shares	Nov. 02, 2019USD ($)	Apr. 30, 2020USD ($)	Mar. 31, 2020USD ($)	Mar. 17, 2020USD ($)	Feb. 01, 2020USD ($)
Debt Instrument [Line Items]
Costs related to debt issuances and amendments				$ (719,000)			$ 3,633,000	$ (375,000)
Loss on extinguishment of debt							(202,000)
Deferred financing costs				$ 23,881,000		$ 2,467,000	$ 23,881,000	$ 2,467,000				$ 2,335,000
Term Loan Facility
Debt Instrument [Line Items]
Borrowing, interest rate				1.90%		3.90%	1.90%	3.90%
Convertible Senior Notes
Debt Instrument [Line Items]
Borrowing, interest rate	8.20%
Long-Term Debt, face amount	$ 805,000,000			$ 805,000,000			$ 805,000,000		$ 805,000,000
Long-Term Debt, conversion of convertible notes | shares	3,656,149
Long-Term Debt, conversion of convertible notes subject to adjustments | shares	4,844,410
Long-Term Debt, interest rate	2.25%			2.25%			2.25%		2.25%
Debt instrument maturity date	Apr. 15, 2025						Apr. 15, 2025
Debt instrument frequency of periodic payments	semi-annually
Debt instrument, date of first required payment	Oct. 15, 2020
Debt instrument, conversion ratio	4.5418
Debt instrument, principal amount for conversion	$ 1,000
Debt instrument, conversion price | $ / shares	$ 220.18			$ 220.18			$ 220.18
Debt instrument, conversion premium	32.50%
Share price | $ / shares	$ 166.17
Debt instrument, convertible, stock price trigger	130.00%
Debt instrument, redemption price, percentage	100.00%
Debt instrument repurchase percentage on conditional basis	100.00%
Deferred financing costs	$ 21,000,000
Convertible Senior Notes | Debt Component
Debt Instrument [Line Items]
Deferred financing costs	16,400,000			$ 14,888,000			$ 14,888,000
Convertible Senior Notes | Equity Component
Debt Instrument [Line Items]
Deferred financing costs	4,600,000
Senior Secured Notes
Debt Instrument [Line Items]
Long-Term Debt, face amount	$ 300,000,000			$ 300,000,000			$ 300,000,000		$ 300,000,000
Long-Term Debt, interest rate	6.25%			6.25%			6.25%		6.25%
Debt instrument maturity date	Apr. 15, 2025						Apr. 15, 2025
Debt instrument frequency of periodic payments	semiannually
Debt instrument, date of first required payment	Oct. 15, 2020
Deferred financing costs	$ 7,800,000
Debt instrument legal fees	$ 2,500,000
ABL senior secured revolving facility
Debt Instrument [Line Items]
Long-Term Debt, face amount				$ 600,000,000			$ 600,000,000			$ 600,000,000	$ 400,000,000
Debt instrument maturity date							Jun. 29, 2023
Repayments of debt					$ 150,000,000
Line of Credit Facility, amount available				292,400,000		$ 540,800,000	$ 292,400,000	$ 540,800,000
Line of Credit Facility, maximum amount outstanding during period				250,000,000		120,000,000	400,000,000	255,000,000
Line of Credit Facility, Average borrowings				$ 250,000,000		$ 32,600,000	$ 276,200,000	$ 108,700,000
Line of Credit Facility, Average interest rate				1.60%		3.50%	2.00%	3.70%
Term Loan Facility
Debt Instrument [Line Items]
Costs related to debt issuances and amendments		$ 1,100,000
Term Loan Facility | Write Off Deferred Financing Costs
Debt Instrument [Line Items]
Loss on extinguishment of debt		$ (200,000)
Term Loan Facility | Prime Rate
Debt Instrument [Line Items]
Line of Credit Facility, interest rate		0.75%	1.00%
Term Loan Facility | London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Line of Credit Facility, interest rate		1.75%	2.00%
Term Loan Facility | London Interbank Offered Rate Floor
Debt Instrument [Line Items]
Line of Credit Facility, interest rate		0.00%

Long-Term Debt - Schedule of Co

Long-Term Debt - Schedule of Components of Convertible Notes (Detail) - USD ($) $ in Thousands		Oct. 31, 2020	Apr. 16, 2020	Feb. 01, 2020	Nov. 02, 2019
Debt Instrument [Line Items]
Principal	[1]	$ 2,316,415		$ 961,415	$ 961,415
Unamortized deferred financing costs		(23,881)		$ (2,335)	$ (2,467)
Convertible Senior Notes
Debt Instrument [Line Items]
Unamortized deferred financing costs			$ (21,000)
Net carrying amount		640,618
Convertible Senior Notes | Debt Component
Debt Instrument [Line Items]
Principal		805,000
Unamortized debt discount		(164,383)
Unamortized deferred financing costs		(14,888)	(16,400)
Net carrying amount		625,729
Convertible Senior Notes | Equity Component
Debt Instrument [Line Items]
Unamortized deferred financing costs			$ (4,600)
Net carrying amount		$ 131,916
[1]	The table above excludes finance lease obligations, debt discount and deferred debt costs.

Long-Term Debt - Schedule of In

Long-Term Debt - Schedule of Interest Expense Related to Convertible Notes (Detail) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Oct. 31, 2020	Oct. 31, 2020	Nov. 02, 2019
Debt Instrument [Line Items]
Amortization of deferred financing costs		$ 3,111	$ 945
Convertible Senior Notes
Debt Instrument [Line Items]
Coupon interest	$ 4,508	9,864
Amortization of debt discount	7,542	16,295
Amortization of deferred financing costs	683	1,476
Convertible Notes interest expense	$ 12,733	$ 27,635

Derivative Instruments And He_3

Derivative Instruments And Hedging Activities - Additional Information (Detail) - Interest Rate Cap Contracts $ in Millions	Oct. 31, 2020USD ($)Derivative
Derivative [Line Items]
Number of credit risk derivatives held | Derivative	1
Amounts reported in Accumulated Other Comprehensive Loss to be reclassified to interest expense, during the next twelve months | $	$ 11.5

Outstanding Interest Rate Deriv

Outstanding Interest Rate Derivative in Qualifying Hedging Relationships (Detail) - Cash Flow Hedging - Derivatives Designated as Hedging Instruments - Interest Rate Swap Contract	9 Months Ended
	Oct. 31, 2020USD ($)Derivative
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Number of Instruments | Derivative	1
Notional Aggregate Principal Amount | $	$ 450,000,000
Interest Swap Rate	2.72%
Maturity Date	Dec. 29, 2023

Derivative Instruments and He_4

Derivative Instruments and Hedging Activities (Detail) - USD ($) $ in Thousands	Oct. 31, 2020	Feb. 01, 2020	Nov. 02, 2019
Interest Rate Swap Contract | Other Liabilities
Derivatives, Fair Value [Line Items]
Derivative Designated as Hedging Instruments Interest Rate Cap Contracts, Liability at Fair Value	$ 34,076	$ 26,220	$ 24,410

Summary of Unrealized Gains and

Summary of Unrealized Gains and Losses Deferred to Accumulated Other Comprehensive Loss (Detail) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Oct. 31, 2020	Aug. 01, 2020	May 02, 2020	Nov. 02, 2019	Aug. 03, 2019	May 04, 2019	Oct. 31, 2020	Nov. 02, 2019
Derivative Instruments Gain Loss [Line Items]
Income tax expense (benefit)	$ (200)	$ (700)	$ (3,600)	$ (400)	$ (3,900)	$ (1,300)
Unrealized gains (losses), net of taxes	583	$ (1,982)	$ (9,609)	(1,003)	$ (10,222)	$ (3,272)	$ (11,008)	$ (14,497)
Derivatives Designated as Hedging Instruments | Interest Rate Derivatives
Derivative Instruments Gain Loss [Line Items]
Unrealized gains (losses), before taxes	804			(1,387)			(15,090)	(20,043)
Income tax expense (benefit)	(221)			384			4,082	5,546
Unrealized gains (losses), net of taxes	$ 583			$ (1,003)			$ (11,008)	$ (14,497)

Reclassification of Gains and L

Reclassification of Gains and Losses from Accumulated Other Comprehensive Loss into Earnings (Detail) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Oct. 31, 2020	Aug. 01, 2020	May 02, 2020	Nov. 02, 2019	Aug. 03, 2019	May 04, 2019	Oct. 31, 2020	Nov. 02, 2019
Reclassification Adjustment Out Of Accumulated Other Comprehensive Income On Derivatives [Line Items]
Interest expense	$ (27,456)			$ (12,149)			$ (70,508)	$ (38,954)
Income tax expense (benefit)	15,088			22,957			(253,327)	50,302
Net reclassification into earnings	2,119	$ 2,049	$ 1,108	500	$ 150	$ (185)	5,276	465
Reclassification out of accumulated other comprehensive income | Derivatives Designated as Hedging Instruments | Accumulated net gain (loss) from cash flow hedges including portion attributable to noncontrolling interest | Interest Rate Cap Contracts
Reclassification Adjustment Out Of Accumulated Other Comprehensive Income On Derivatives [Line Items]
Interest expense	2,919			691			7,271	635
Income tax expense (benefit)	(800)			(191)			(1,995)	(170)
Net reclassification into earnings	$ 2,119			$ 500			$ 5,276	$ 465

Changes in Accumulated Other Co

Changes in Accumulated Other Comprehensive Loss (Detail) $ in Thousands	9 Months Ended
	Oct. 31, 2020USD ($)
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance at beginning of period	$ 528,149
Balance at end of period	286,576
Derivative Instruments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance at beginning of period	(18,960)
Unrealized losses, net of related tax benefit of $4.1 million	(11,008)
Amount reclassified into earnings, net of related taxes of $2.0 million	5,276
Balance at end of period	$ (24,692)

Changes in Accumulated Other _2

Changes in Accumulated Other Comprehensive Loss (Parenthetical) (Detail) - Derivative Instruments $ in Millions	9 Months Ended
	Oct. 31, 2020USD ($)
Accumulated Other Comprehensive Income (Loss) [Line Items]
Unrealized losses on Interest Rate Cap Contracts, Tax	$ 4.1
Amount reclassified into earnings on Interest Rate Cap Contracts, Tax	$ 2

Fair Values of Financial Assets

Fair Values of Financial Assets and Hierarchy of Level of Inputs (Detail) - USD ($) $ in Thousands	Oct. 31, 2020	Feb. 01, 2020	Nov. 02, 2019
Fair Value, Inputs, Level 1
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Cash equivalents (including restricted cash)	$ 1,001,416	$ 369,733	$ 7,275

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Detail)	3 Months Ended	9 Months Ended
	Oct. 31, 2020USD ($)Store	Oct. 31, 2020USD ($)Store
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Impairment charges - long-lived assets	$ 2,575,000	$ 5,575,000
Fair Value, Inputs, Level 3
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Fair value of impaired assets	$ 0	$ 0
Assets Impairments
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Impairment of store level assets, number of stores | Store	10	14
Impaired Lease Assets | Fair Value, Inputs, Level 3
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Impairment of store level assets, number of stores | Store		1
Fair value of impaired assets	$ 2,900,000	$ 2,900,000

Fair Values of Financial Liabil

Fair Values of Financial Liabilities (Detail) - USD ($) $ in Thousands		Oct. 31, 2020	Feb. 01, 2020	Nov. 02, 2019
Carrying Amounts And Fair Values Of Financial Instruments [Line Items]
Long-Term Debt, Principal Amount	[1]	$ 2,316,415	$ 961,415	$ 961,415
Long-Term Debt, Fair Value	[1]	2,427,398	959,899	957,900
Term B-5 Loans
Carrying Amounts And Fair Values Of Financial Instruments [Line Items]
Long-Term Debt, Principal Amount		961,415	961,415	961,415
Long-Term Debt, Fair Value		944,590	$ 959,899	$ 957,900
Convertible Notes
Carrying Amounts And Fair Values Of Financial Instruments [Line Items]
Long-Term Debt, Principal Amount		805,000
Long-Term Debt, Fair Value		918,183
Secured Notes
Carrying Amounts And Fair Values Of Financial Instruments [Line Items]
Long-Term Debt, Principal Amount		300,000
Long-Term Debt, Fair Value		314,625
ABL Line of Credit
Carrying Amounts And Fair Values Of Financial Instruments [Line Items]
Long-Term Debt, Principal Amount		250,000
Long-Term Debt, Fair Value		$ 250,000
[1]	The table above excludes finance lease obligations, debt discount and deferred debt costs.

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Nov. 02, 2019	Oct. 31, 2020	Nov. 02, 2019	Feb. 01, 2020
Income Tax Disclosure [Line Items]
Income tax expense (benefit)	$ 15,088	$ 22,957	$ (253,327)	$ 50,302
Effective tax rate			40.50%	16.30%
Federal statutory rate			21.00%
Tax rate impact, permanent benefits related to stock compensation			4.10%
Tax rate impact related to various provisions of CARES Act			12.80%
Deferred tax asset for net operating loss	22,200		$ 22,200
Valuation allowances	12,400	$ 8,700	12,400	$ 8,700	$ 9,800
Puerto Rico
Income Tax Disclosure [Line Items]
Tax credit carryforwards	12,900		12,900
Amount of alternative minimum tax credits	1,300		$ 1,300
Alternative minimum tax credits, expiration life			indefinite life
Federal
Income Tax Disclosure [Line Items]
Tax credit carryforwards	2,500		$ 2,500
Tax credit expiration period			2040
State and local jurisdiction
Income Tax Disclosure [Line Items]
Deferred tax asset for net operating loss	21,900		$ 21,900
Tax credit carryforwards	9,100		$ 9,100
Tax credit expiration period			2021
State and local jurisdiction | Minimum
Income Tax Disclosure [Line Items]
Net operating losses subject to expiration year			2021
State and local jurisdiction | Maximum
Income Tax Disclosure [Line Items]
Net operating losses subject to expiration year			2040
Puerto Rico
Income Tax Disclosure [Line Items]
Deferred tax asset for net operating loss	$ 300		$ 300
Net operating losses subject to expiration year			2025

Net Deferred Taxes (Detail)

Net Deferred Taxes (Detail) - USD ($) $ in Thousands	Oct. 31, 2020	Feb. 01, 2020	Nov. 02, 2019
Income Tax Disclosure [Abstract]
Deferred tax asset	$ 4,596	$ 4,678	$ 4,066
Deferred tax liability	204,745	182,288	171,626
Net deferred tax liability	$ 200,149	$ 177,610	$ 167,560

Capital Stock - Additional Info

Capital Stock - Additional Information (Detail) - USD ($)	Aug. 14, 2019	Mar. 31, 2020	Oct. 31, 2020	Aug. 01, 2020	May 02, 2020	Nov. 02, 2019	Aug. 03, 2019	May 04, 2019	Oct. 31, 2020
Statement Equity Components [Line Items]
Shares Used for Tax Withholdings			$ 2,911,000	$ 2,350,000	$ 7,383,000	$ 112,000	$ 11,521,000	$ 7,538,000
2019 Stock Repurchase Program
Statement Equity Components [Line Items]
Stock repurchase program, authorized amount	$ 400,000,000
Stock repurchase program, authorized execution month and year	2021-08
2020 Stock Repurchase Program
Statement Equity Components [Line Items]
Common stock repurchased, shares		243,573
Common stock repurchased, value		$ 50,200,000
Remaining authorized repurchase amount			$ 348,400,000						$ 348,400,000
Treasury Stock
Statement Equity Components [Line Items]
Shares Used for Tax Withholdings (in shares)									68,180
Shares Used for Tax Withholdings									$ 12,600,000

Computation of Basic and Dilute

Computation of Basic and Diluted Net Income (Loss) per Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Nov. 02, 2019	Oct. 31, 2020	Nov. 02, 2019
Basic net income (loss) per share
Net income (loss)	$ 8,016	$ 96,459	$ (372,493)	$ 258,791
Weighted average number of common shares – basic	66,083	65,959	65,867	65,994
Net income (loss) per common share – basic	$ 0.12	$ 1.46	$ (5.66)	$ 3.92
Diluted net income (loss) per share
Net income (loss)	$ 8,016	$ 96,459	$ (372,493)	$ 258,791
Weighted average number of common shares – basic	66,083	65,959	65,867	65,994
Assumed exercise of stock options and vesting of restricted stock	637	1,200		1,393
Weighted average number of common shares – diluted	66,720	67,159	65,867	67,387
Net income (loss) per common stock - diluted	$ 0.12	$ 1.44	$ (5.66)	$ 3.84

Net Income (Loss) Per Share - A

Net Income (Loss) Per Share - Additional Information (Detail) - $ / shares	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Nov. 02, 2019	Oct. 31, 2020	Nov. 02, 2019	Apr. 16, 2020
Convertible Senior Notes
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Debt instrument, conversion price	$ 220.18		$ 220.18		$ 220.18
Stock Option, Restricted Stock and Restricted Stock Unit Awards
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Anti-dilutive shares excluded from diluted net (loss) income per share	585,000	350,000	2,010,000	450,000

Stock-Based Compensation - Addi

Stock-Based Compensation - Additional Information (Detail)	9 Months Ended
	Oct. 31, 2020shares
Performance Stock Units
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Service-based awards, vesting period	3 years
Service-based awards, service period	3 years
Performance Stock Units | Minimum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Target award threshold range	50.00%
Performance Stock Units | Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Target award threshold range	200.00%
2013 Omnibus Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares available for grant equity awards	2,424,032

Non-Cash Stock Compensation Exp

Non-Cash Stock Compensation Expense (Detail) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Oct. 31, 2020	Nov. 02, 2019	Oct. 31, 2020	Nov. 02, 2019
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Non-Cash Stock Compensation	[1]	$ 13,406	$ 9,568	$ 43,451	$ 30,542
Restricted Stock and Restricted Stock Unit Grants
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Non-Cash Stock Compensation	[2]	6,410	3,910	19,048	14,453
Stock Option Grants
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Non-Cash Stock Compensation	[2]	4,679	4,567	15,707	13,751
Performance Stock Unit Grants
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Non-Cash Stock Compensation	[2]	$ 2,317	$ 1,091	$ 8,696	$ 2,338
[1]	The amounts presented in the table above exclude taxes. For the three and nine month periods ended October 31, 2020, the tax benefit related to the Company’s non-cash stock compensation was approximately $2.3 million and $8.3 million, respectively. For the three and nine month periods ended November 2, 2019, the tax benefit related to the Company’s non-cash stock compensation was approximately $1.7 million and $6.4 million, respectively.
[2]	Included in the line item “Selling, general and administrative expenses” in the Company’s Condensed Consolidated Statements of Income (Loss).

Non-Cash Stock Compensation E_2

Non-Cash Stock Compensation Expense (Parenthetical) (Detail) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Nov. 02, 2019	Oct. 31, 2020	Nov. 02, 2019
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Non-Cash Stock Compensation tax benefit	$ 2.3	$ 1.7	$ 8.3	$ 6.4

Stock Option Transactions (Deta

Stock Option Transactions (Detail)	9 Months Ended
	Oct. 31, 2020$ / sharesshares
Number of Shares
Options Outstanding at Beginning of Period | shares	1,890,955
Options Granted | shares	242,765
Options Exercised | shares	(572,756)	[1]
Options Forfeited | shares	(33,421)
Options Outstanding at End of Period | shares	1,527,543
Weighted Average Exercise Price Per Share
Options Outstanding at Beginning of Period | $ / shares	$ 94.17
Options Granted | $ / shares	180.78
Options Exercised | $ / shares	42.05	[1]
Options Forfeited | $ / shares	112.74
Options Outstanding at End of Period | $ / shares	$ 127.07
[1]	Options exercised during the nine month period ended October 31, 2020 had a total intrinsic value of $ 88.2

Stock Option Transactions (Pare

Stock Option Transactions (Parenthetical) (Detail) $ in Millions	9 Months Ended
	Oct. 31, 2020USD ($)
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Share based compensation option exercised total intrinsic value	$ 88.2

Stock Options Vested and Expect

Stock Options Vested and Expected to Vest (Detail) $ / shares in Units, $ in Millions	9 Months Ended
	Oct. 31, 2020USD ($)$ / sharesshares
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Vested and expected to vest, Options | shares	1,527,543
Vested and expected to vest, Weighted Average Remaining Contractual Life (Years)	6 years 2 months 12 days
Vested and expected to vest, Weighted Average Exercise Price | $ / shares	$ 127.07
Vested and expected to vest, Aggregate Intrinsic Value | $	$ 101.8

Weighted Average Assumptions Us

Weighted Average Assumptions Used to Estimate Fair Value of Stock Option (Detail)	9 Months Ended
	Oct. 31, 2020$ / shares
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Risk-free interest rate, minimum	0.45%
Risk-free interest rate, maximum	1.48%
Expected volatility, minimum	35.00%
Expected volatility, maximum	36.00%
Expected life (years)	6 years 3 months
Contractual life (years)	10 years
Expected dividend yield	0.00%
Weighted average grant date fair value of options issued	$ 63.62

Award Grant, Vested and Forfeit

Award Grant, Vested and Forfeiture Transactions (Detail) - Non Vested Restricted Stock	9 Months Ended
	Oct. 31, 2020$ / sharesshares
Number of Shares
Non-Vested Awards Outstanding at Beginning of Period | shares	451,774
Awards Granted | shares	185,349
Awards Vested | shares	(195,842)	[1]
Awards Forfeited | shares	(12,901)
Non-Vested Awards Outstanding at End of Period | shares	428,380
Weighted Average Grant Date Fair Value Per Award
Non-Vested Awards Outstanding at Beginning of Period | $ / shares	$ 131.03
Awards Granted | $ / shares	186.40
Awards Vested | $ / shares	112.03	[1]
Awards Forfeited | $ / shares	142.26
Non-Vested Awards Outstanding at End of Period | $ / shares	$ 163.41
[1]	Restricted stock awards vested during the nine month period ended October 31, 2020 had a total intrinsic value of $36.3 million.

Award Grant, Vested and Forfe_2

Award Grant, Vested and Forfeiture Transactions (Parenthetical) (Detail) $ in Millions	9 Months Ended
	Oct. 31, 2020USD ($)
Restricted Stock Issuances
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share based compensation awards vested total intrinsic value	$ 36.3

Performance Stock Units Transac

Performance Stock Units Transactions (Detail) - Performance Stock Units	9 Months Ended
	Oct. 31, 2020$ / sharesshares
Number of Shares
Non-Vested Awards Outstanding at Beginning of Period | shares	80,951
Awards Granted | shares	74,783
Awards Forfeited | shares	(1,783)
Non-Vested Awards Outstanding at End of Period | shares	153,951
Weighted Average Grant Date Fair Value Per Award
Non-Vested Awards Outstanding at Beginning of Period | $ / shares	$ 173.87
Awards Granted | $ / shares	179.46
Awards Forfeited | $ / shares	170.08
Non-Vested Awards Outstanding at End of Period | $ / shares	$ 176.63

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - USD ($)	Oct. 31, 2020	Jun. 30, 2020	Feb. 01, 2020	Nov. 02, 2019	Nov. 30, 2005
Commitments And Contingencies Disclosure [Line Items]
Settlements of legal matters		$ 19,600,000
Letters of credit, outstanding amount	$ 57,600,000		$ 53,100,000	$ 59,200,000
Purchase commitments related to goods or services	1,090,700,000
Death benefits					$ 1,000,000
Guarantee Performance Under Insurance And Utility Agreement
Commitments And Contingencies Disclosure [Line Items]
Letters of credit, outstanding amount	47,200,000		46,600,000	50,800,000
Merchandising Agreement
Commitments And Contingencies Disclosure [Line Items]
Letters of credit, outstanding amount	10,400,000		6,500,000	8,400,000
Letters of Credit | ABL senior secured revolving facility
Commitments And Contingencies Disclosure [Line Items]
Letters of credit, maximum borrowing capacity	$ 292,400,000		$ 501,800,000	$ 540,800,000